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 Respiring organisms derive energy mainly from electron transfer reactions that are 
coupled to the translocation of ions across the cell membrane. This process is performed by a 
group of membrane-localized protein complexes that hold different cofactors with redox 
properties, such as flavins, hemes, and other iron-containing centers. These redox complexes 
constitute the electron transport or respiratory chain.  
 This thesis will cover the study of three different flavin-containing proteins related to the 
electron transport chain:  
• The type 2 NADH dehydrogenase (NDH-2) from Streptococcus agalactiae 
• The sulfide:quinone oxidoreductase (SQR) from the archaeon Caldivirga maquilingensis 
• The NDH-2 from Thermus thermophilus, now re-classified as a coenzyme A disulfide 
reductase (CoADR) 
 
 NDH-2 catalyzes the same reaction (NADH:quinone oxidoreductase) as complex I, 
however it is unable to translocate protons across the membrane. Absent in mammalian 
mitochondria and the main or only respiratory NADH dehydrogenase present in certain 
pathogens, it has recently gained interest as a putative drug target. S. agalactiae is the major 
cause of meningitis and sepsis in a newborn’s first week of life in the United States. This 
organism encodes an NDH-2 as its only NADH dehydrogenase, and respiration has been shown 
to be important for virulence in an animal model. Here, NDH-2 was found to be the sole point of 
entry for electrons to the S. agalactiae respiratory chain. Additionally, in a mouse model of 




The protein was expressed, purified, biochemically characterized and used for in vitro screening 
of inhibitors. Several compounds were found to block activity of the protein and one even 
inhibited respiration in whole cells. 
 SQRs (H2S + Q → S0 + QH2) are ubiquitous enzymes that can provide electrons to 
respiratory or photosynthetic electron transfer chains, besides having roles in sulfide 
detoxification and homeostasis. C. maquilingensis is a hyperthermophilic archaeon encoding a 
type III SQR, which lacks a cysteine residue involved in flavin binding in other SQR classes. 
This protein was expressed, purified and biochemically characterized, showing sulfide oxidation 
in the presence of quinone. The mode of membrane binding of CmSQR was studied by 
constructing truncated versions of the enzyme, lacking one or both amphipathic C-terminal 
helices. These variants were expressed as inactive soluble enzymes and lack of activity was 
attributed to the mutation of a single leucine residue, presumably involved in quinone 
interaction. Further mutations were made based on a homology model for CmSQR and crystal 
structures available for other SQR types, to characterize the quinone and flavin binding sites. 
Lastly, the oligomeric state of CmSQR was studied and the protein determined to be a dimer by 
different methods, including gel filtration, native gel and crosslinking.  
T. thermophilus aerobic NDH-2 exhibits very low activity (1 electron/sec) for NADH 
oxidation in the presence of quinone analogs. Recently, the crystal structure for TtNDH-2 was 
solved indicating strong similarity to Pyrococcus horikoshii CoADR (NADH: Coenzyme A 
disulfide oxidoreductase) and making us re-evaluate this assignment. Biochemical assays 
showed the enzyme CoADR activity is 6-fold greater than its NDH-2 activity. Kinetic 
parameters are also similar to other known CoADRs, and the enzyme can be inhibitied by a 











To my grandma Nelly, 
the most determined, fun and 


















 This work would have not been possible without the support of many people, inside and 
outside of the lab, and I will always be grateful to them.  
I would first like to thank Bob (Prof. Robert Gennis), my advisor, for giving me the 
opportunity to join his lab and supporting me through all these years. I feel incredibly lucky to 
have spent all this time with him, as his interest and curiosity in basically every topic is 
contagious, and I believe I might have got some of that. He is not only a remarkable scientist and 
a supportive mentor, always willing to listen and discuss new ideas, but a patient and kind human 
being, something I also hope to have caught a little. 
Second, I am hugely indebted to Lici Schurig-Briccio, she has been my family, friend and 
mentor through all my time in Champaign-Urbana, and I certainly would not be here if it were 
not for her and Juan Luis, her husband. She is an amazing and passionate scientist, and I am sure 
some day she would make a wonderful advisor.  
Long hours staring at screens, discussions over coffee and all the many meals shared, 
made the lab feel like a second home, and lab members like a second family. Besides from Bob 
and Lici, I am thankful to all those in lab that have overlapped with my stay. Specially Sylvia, 
who has helped me so much during my time spent in UIUC, and that together with Ranjani and 
Padmaja, have become my lab sisters (you will not get rid of me that easily and I will keep in 
touch even if you move across the world, not only to other side of the country). Other lab 
members I would like to mention include Ash Pawate, who encouraged me to even pursue a 
PhD, Ziqiao “Tim” Ding, one of the very few to share the lab with me from beginning to end, 




and Jim Hemp, also helped me in different ways, and together with the several visiting students 
hosted over the years, contributed to a pleasant lab environment.  
On top of the scientist I had the pleasure to work with in the Gennis lab, I need to thank 
the collaborators that have enthusiastically contributed with their expertise to a broader 
understanding of the projects we worked on. 
Outside of the lab, two fantastic roommates have dealt with my ups and downs in 
research and life in Champaign-Urbana: Jin and Pao. Their support has been essential for this 
journey, from cooking meals in times of quals, to planning surprise birthday parties that helped 
with homesickness, and basically hours and hours of listening to our mutual first-world 
problems. I also need to thank their husbands for their understanding and for acting like the 
brothers I never had. I also want to thank all those friends with whom I drank mate, played 
volleyball or simply hanged out with, and to those who planned summer activities and cooked 
asados, making the time away from lab enjoyable and memorable. Specially, my Argentinian 
family/friends who have taken care of me since the moment I have arrived. 
I would also like to thank Drs. Imlay, Cheng and Oldfield for taking the time to listen to 
my science and for making the evaluation stages actual learning moments.  
Finally, my parents, sister and grandma have been the greatest cheerleaders throughout 
this race and I am extremely thankful for their love and support. I know they are not happy with 
me being so far away, but I greatly appreciate their efforts to hide it. I could not have made it 
without them. 
 





TABLE OF CONTENTS 
 
1. INTRODUCTION…………………………………………………………………...………1 
1.1. Cellular respiration……………………………………………………………………….1 
1.2. NADH dehydrogenases…………………………………………………………………..2 
1.3. Type 2 NADH dehydrogenase (NDH-2)…………………………………………………4 
1.4. Scope of this thesis……………………………………………………………………….5 
2. TYPE-2 NADH DEHYDROGENASE IS THE ONLY POINT OF ENTRY FOR 
ELECTRONS INTO THE STREPTOCOCCUS AGALACTIAE RESPIRATORY 
CHAIN AND IS A POTENTIAL DRUG TARGET……………………………………….7 
2.1. Introduction……………………………………………………………………………….7 
2.2. Materials and Methods……………………………………………………………….…10 
2.3. Results…………………………………………………………………………………...18 
2.4. Discussion……………………………………………………………………………….28 
2.5. Supplementary Information..............................................................................................33 
3. CHARACTERIZATION OF THE TYPE III SULFIDE:QUINONE 
OXIDOREDUCTASE FROM CALDIVIRGA MAQUILINGENSIS AND ITS 
MEMBRANE BINDING …………………………………………………………………..36 
3.1. Introduction……………………………………………………………………………...36 






4. STUDIES ON THE CALDIVIRGA MAQUILINGENSIS TYPE III SULFIDE 
QUINONE OXIDOREDUCTASE: THE OLIGOMERIC STATE IS INDEPENDENT 
FROM MEMBRANE BINDING ……………...…………………………………………..60 
4.1. Introduction……………………………………………………………………………...60 
4.2. Materials and Methods………………………………………………………………….61 
4.3. Results……………………………………………………..…………………………….66 
4.4. Discussion….……………………………………………………………………………77 
5. THE NADH-DEPENDENT COENZYME A DISULFIDE REDUCTASE FROM 
THERMUS THERMOPHILUS…..………………………………………………………...82 
5.1. Introduction…..………………………………………………………………………….82 










1.1. CELLULAR RESPIRATION  
Respiring organisms are able to conserve energy from electron transfer reactions through redox 
complexes, coupled to the translocation of monovalent ions across a semipermeable membrane 
[1]. This group of membrane-localized redox components constitute the electron transport or 
respiratory chain, of which the classic example corresponds to the eukaryotic mitochondrial 




Figure 1.1. Schematic representation of the electron transport chain from mammalian mitochondria. 
Adapted from [2].  
 
 The mitochondrial electron transport chain in mammalian cells consists of four 
transmembrane multi-subunit complexes (I, II, III and IV) and two mobile electron carriers 
(ubiquinone and cytochrome c). Complex I (NADH dehydrogenase) and complex II (succinate 




derived from the oxidation of nutrients. These flavin-containing complexes are then able to 
reduce the lipid soluble quinones embedded in the membrane bilayer, which in turn pass on the 
electrons to complex III (bc1 complex). Complex III then is able to reduce cytochrome c, a 
soluble protein located in the intermembrane space, which will transfer the electrons one-by-one 
to complex IV (cytochrome c oxidase). This terminal oxidase will finally use these electrons to 
reduce O2 to H2O. During this energy-favorable electron transfer process, the transmembrane 
complexes I, III and IV are able to utilize the released energy to translocate protons from the 
matrix to the intermembrane space, building up an electrochemical gradient. This proton gradient 
can be later used by the ATP synthase (also called complex V) to drive the synthesis of ATP, by 
translocation of the ions back to the matrix.  
 
1.2. NADH DEHYDROGENASES 
The main reducing equivalent synthesized by the cell central metabolism is NADH, 
making it the principal electron donor to respiratory chains. In prokaryotes, NADH is produced 
in the cytosol and respiration takes place in the cytoplasmic membrane. Besides the five known 
mitochondrial complexes from mammalian chains, prokaryotes can show additional components 
[3]. The existence of alternative electron transport chains provides a remarkable flexibility and 
diversity, allowing adaptation of these organisms to thrive under different environmental 
conditions. This is achieved by their ability to use different organic and inorganic compounds as 
electron donors (NADH, lactate, sulfide, hydrogen, etc.) or acceptors (oxygen, nitrate, sulfate, 
fumarate, etc.).  
 Another remarkable feature of the prokaryote respiratory chain is its branched nature, 




present in an organism at different times. This confers the ability to tune the chain composition 
based on substrate availability and energy needs of the cell. The first branch point in bacteria is 
the NADH oxidation step, which can be catalyzed by three different NADH dehydrogenases 
(NDHs): complex I (also called NDH-1), the type 2 NDH (NDH-2) and the Na+-pumping 
NADH-quinone oxidoreductase (Na+-NQR) [4] (Fig. 1.2). All three types are able to catalyze 
essentially the same reaction (NADH oxidation/quinone reduction); however, some of them 
show additional features such as H+ (NDH-1) or Na+ (NQR) translocation. This characteristic 
allows for a higher energy yield in the form of proton (or sodium) motive force. 
NDH-1 is a multi-subunit complex containing several cofactors including a flavin 
mononucleotide (FMN) molecule and a number of [Fe-S] clusters. It is a transmembrane 
complex, able to translocate H+, leading to higher energy conservation [5]. NDH-2, on the other 
hand, is a dimeric membrane bound enzyme, holding a single flavin cofactor per monomer and 
unable to translocate protons. A large electrochemical potential can reverse electron transport 
chain reactions. NDH-2 does not contribute directly to building a H+ gradient and is thought to 
be used during growth on high energy substrates, favoring higher rates of NADH reoxidation [6]. 
Na+-NQR, the Na+-pumping NDH, was originally discovered and characterized in marine 
bacteria. It is thought that these organisms evolved to have a bioenergetic system based on Na+ 
chemiosmosis consistent with the highly saline environment they live in. More recently, the Na+-
NQR has been suggested to play an important role in the metabolism of important human 
pathogens considering that similar Na+ levels to seawater can be found in different host 






Figure 1.2. The three types of NADH dehydrogenases. (A) NDH-1 or Complex I, (B) NDH-2 and (C) 
Na+-NQR.  
 
1.3. TYPE 2 NADH DEHYDROGENASE (NDH-2) 
NDH-2, also called the rotenone-insensitive NDH, can be found in every domain of life and 
different examples have been characterized from bacteria, archaea, yeast, plants and protozoan 
parasites [6]. It is absent in mammalian mitochondria and the only type of NDH found in certain 
pathogens, making it an attractive drug target [8]. Moreover, based on studies using NDH-2 for 
complementation of complex I deficiencies, it has been proposed as a potential treatment for 
diseases like Parkinson’s [9]. 
Unlike the transmembrane multi-subunit complex I, NDH-2 is a homodimer containing a 
single flavin cofactor per monomer. It is only monotopically bound to the cytoplasmic surface of 
the bacterial membrane, and therefore is unable to translocate ions across the membrane. Based 
on sequence analysis three types of NDH-2s had been proposed (A, B and C), each characterized 
by the presence of certain conserved amino acid motifs [6].  Type A NDH-2s were described to 
have two GXGXXG dinucleotide binding motifs (one for FAD and one for NADH binding) and 
to be found in all kingdoms. Type B, with an additional Ca2+-binding EF-hand motif, could be 
found exclusively in fungi and plants. Lastly, type C enzymes holding a single GXGXXG motif 




more likely represents sulfide quinone reductases (SQRs) (S2- + Q à Sn + QH2), showing a 
characteristic cysteine involved in catalysis [10, 11].  
A recent phylogenetic study from Marreiros et al. [12] has proposed a new classification, 
dividing NDH-2s into four distinct groups. These new groups (A-D) do not correlate with the 
taxonomic tree. Briefly, bacterial, archaeal and eukaryotic variants can be found in different 
groups, based on the presence of a C-terminal extension with similarity to the selenophosphate 
synthetase family (group A) or two cysteines predicted to form a disulfide bond (group C). 
Additionally, group B consists of solely eukaryotic examples from fungi and protists, and group 
D comprises a large set of sequences further subdivided into five divergent clusters, including all 
those found in firmicutes, those with a putative CXXC metal binding motif, and some variants 
from yeasts and protozoan parasites.  
 
1.4. SCOPE OF THIS THESIS 
As exposed by the different attempts to classify and group NDH-2s, identification of these 
proteins from their sequences can be challenging, since they lack distinctive features to separate 
themselves from other two-dinucleotide binding domain flavoproteins (tDBDFs) [13].  
This work was initially focused on NDH-2s. First, the NDH-2 from the pathogenic 
bacterium Streptococcus agalactiae was characterized and shown to be important for virulence. 
S. agalactiae’s genome encodes this enzyme as its only NDH, making it a potential drug target; 
therefore after investigating its importance in virulence, a screening for inhibitors was also 
performed. Next, based on Melo’s classification [6], a type C NDH-2 was also studied and found 
to be an SQR. This was further characterized, with emphasis in its membrane binding and 




including NDH-2s.  Finally, the previously characterized NDH-2 from Thermus thermophilus 
was analyzed after obtaining its crystal structure, and re-classified as a coenzyme A disulfide 
reductase (CoADR). CoADRs are soluble enzymes involved in protection against oxidative 
stress, catalyzing oxidation of NAD(P)H and reduction of Coenzyme A disulfide (NAD(P)H + 
CoA-S-S-CoA à NAD(P)+ + H+ + 2CoASH) [14, 15]. T. thermophilus CoADR is specific for 
NADH, and its structure shows a covalently bound CoA molecule upon purification. The 
quinone-bound structure indicates the quinone binds at the CoAD binding pocket, possibly 





2. TYPE-2 NADH DEHYDROGENASE IS THE ONLY POINT OF ENTRY FOR 
ELECTRONS INTO THE STREPTOCOCCUS AGALACTIAE RESPIRATORY 
CHAIN AND IS A POTENTIAL DRUG TARGET* 
*Adapted with permission of the authors. mBio July/August 2018; 9:e01034-18. doi: 10.1128/mBio.01034-18. 
Copyright belongs to Andrea M. Lencina, Thierry Franza, Matthew J. Sullivan, Glen C. Ulett, Deepak S. Ipe, 
Philippe Gaudu, Robert B. Gennis and Lici A. Schurig-Briccio.  
 
2.1. INTRODUCTION 
Streptococcus agalactiae (GBS, Group B Streptococcus) is a facultative, fermentative 
commensal bacterium normally living in the gut and urogenital tract of healthy individuals.  It 
belongs to the family of Streptococcaceae, many of which are opportunistic pathogens, and is 
able to transition to invasive niches, causing excessive inflammation, sepsis and death [16]. S. 
agalactiae is the major cause of meningitis and sepsis in a newborn’s first week of life in the 
United States, as well as a considerable cause of pneumonia and sepsis in immunocompromised 
adults [17]. In neonates, S. agalactiae is transmitted by the mother during birth via aspiration of 
fluids. Although most transmission can be prevented by intravenously antibiotic administration 
during labor, allergies and emerging resistance to such antibiotics are an increasing concern [17]. 
S. agalactiae is also associated with a large fraction of urinary tract infections in the elderly and 
nursing home residents, including kidney and bladder infections [18]. 
Despite its capacity for fermentative metabolism, S. agalactiae can perform aerobic 
respiration in the presence of external sources of heme and quinone. Within the same operon, the 
genome encodes a cytochrome bd oxygen reductase (cyt bd encoded by cydAB), a putative type-
2 NADH dehydrogenase (NDH-2 encoded by ndh) and a 1,4-dihydroxy-2-naphthoate 




the synthesis of demethylmenaquinone (DMK-10). However, genes other than menA that are 
required to synthesize MK are not present in S. agalactiae which is, therefore, not able to 
synthesize DMK-10 from chorismate [21]. Disabling cyt bd (DcydA) results in decreased organ 
colonization and increased survival of neonatal rats compared to wild type (WT) infection, 
indicating a link between respiration and virulence [19, 22].  
NDH-2 is a homodimeric flavoprotein that catalyzes the oxidation of NADH with the 
concomitant reduction of quinone. It is a monotopic membrane enzyme that binds at the 
cytoplasmic surface of the bacterial membrane in order to have access to one of its substrates 
(quinone) but has no transmembrane domain [23-26]. Cyt bd is a transmembrane, heme-
containing two-subunit enzyme (CydA, CydB) that catalyzes menaquinol:O2 oxidoreductase 
activity [27]. The chemical reaction catalyzed by cyt bd results in the net electrogenic transfer of 
two protons  from the cytoplasm to the extracellular space, contributing to the proton motive 
force (PMF) [27, 28]. Both NDH-2 and cyt bd are absent in mammalian mitochondria, making 
them plausible drug targets [8]. NDH-2, which plays an important role in the pathogen survival 
and virulence, has been pursued as a possible drug target in Mycobacterium tuberculosis [29, 
30], Toxoplasma gondii [31] and Plasmodium falciparum [32, 33]. 
To understand the significance of NDH-2 in S. agalactiae survival and virulence and the 
consequences of its deficiency, it is important to consider the main metabolic strategies used by 
this pathogen (Fig. 2.1). Glycolysis yields 2 equivalents each of pyruvate and NADH. Growth 
requires not only ATP production but also a way to recycle NADH to NAD+ to allow glycolysis 
to proceed. Fig. 2.1 shows alternative pathways for pyruvate catabolism in S. agalactiae that 
contribute to different degrees depending on growth conditions. Note that this organism does not 




   
 
Figure 2.1. Pyruvate catabolism in S. agalactiae. One molecule of glucose will produce two of pyruvate 
via glycolysis, with net reduction of 2 NADH. Fermentation of pyruvate, will allow NADH reoxidation 
for its recycling and use in a new round of glycolysis. (A) In the absence of oxygen, acetyl-CoA is made 
from pyruvate by pyruvate formate lyase (PFL), allowing synthesis of fatty acids. The main fermentation 
product is lactate, but significant amounts of ethanol, acetate, acetoin and diacetyl are also found [35]. 
Under aerobic conditions, production of acetoin, diacetyl and acetate are prevalent over ethanol. (B) In 
the presence of oxygen without addition of external heme or quinone sources (respiration non-permissive 
condition), lactate is still the main fermentation product, which leads to a significant decrease in pH.  (C) 
Upon addition of external heme and quinone, in the presence of oxygen (respiration permissive 
condition), the respiratory chain (NDH-2/cyt bd) becomes functional. Metabolism is shifted towards 
production of acetate, acetoin and diacetyl, reducing the amount of pyruvate available to be converted 
into lactate. This results in less acidification of the medium in stationary phase. Higher growth yield is 
achieved as a result of enhanced ATP formation via the Pta-Ack pathway, and possibly oxidative 
phosphorylation by the electron transport chain. Boxes indicate the main products for each condition. 
ACK: acetate kinase; ALS: acetolactate synthase; ALDB: 2-acetolactate decarboxylase; LDH: lactate 
dehydrogenase; PDH: pyruvate dehydrogenase; PTA: phosphate transacetylase; n.e.: non-enzymatic 





Under anaerobic growth conditions, S. agalactiae must grow strictly by fermentation [35, 
36, 38]. Under growth conditions in which sugar metabolism is rapid and there is constant 
NADH production, NAD+ is regenerated by converting pyruvate to lactate via lactate 
dehydrogenase (homolactic fermentation) (Fig. 2.1A).  Some growth conditions however, result 
in a shift towards mixed-acid fermentation, in which pyruvate can be catabolized by pyruvate 
dehydrogenase, pyruvate formate lyase and/or acetolactate synthase, yielding a variety of end 
products, including formate/CO2, acetate and acetoin. (Fig. 2.1B). The presence of oxygen has 
several consequences. First, pyruvate formate lyase is particularly susceptible to inactivation by 
oxygen. Second, if both heme and quinone can be acquired from the surroundings, S. agalactiae 
utilizes its respiratory chain to regenerate NAD+, generate a PMF, enhance ATP production via 
acetate kinase (Ack) and possibly oxidative phosphorilation, and reduce the concentration of O2 
(Fig 2.1C). Finally, S. agalactiae also has a water-forming NADH oxidase (Nox-2) [38], a 
soluble enzyme that reduces oxygen to water and regenerates NAD+ but does not contribute to 
the energy needs of the cell. In the absence of heme and quinone, S. agalactiae relies on Nox-2 
for recycling NAD+ to feed glycolysis, to synthesize fatty acids and for reducing oxygen to 
water. 
In this study, it is demonstrated that NDH-2 is an essential element for aerobic respiration 
and that disabling this enzyme reduces virulence in a mouse model of systemic infection. In 
addition, the S. agalactiae NDH-2 is purified, biochemically characterized and proven a potential 
drug target for GBS. 
 





Gene sequences encoding S. agalactiae (gbs1788), S. aureus (SAB0708) and C. thermarum 
(Accession No. ZP_08531709.1) NDH-2s were retrieved from the National Center for 
Biotechnology Information (NCBI) database. Amino acid sequence alignments were performed 
using CLUSTAL W [39]. 
 
Bacterial strains and growth conditions 
Strains and plasmids used in this work are listed in Table 2.1. S. agalactiae NEM316, a capsular 
serotype III strain with a fully sequenced genome, was used as WT [34, 40]. For growth in liquid 
media, cells were initially grown overnight at 37°C in M17 broth supplemented with 0.2 % 
glucose and 80 µM menaquinone (MK-4), under static microaerobic conditions. These overnight 
cultures were used to inoculate tubes with M17 broth (1/10 volume ratio) supplemented with 5 
µM riboflavin, to an initial OD600 » 0.05. Culture tubes were incubated at 37°C, first statically 
until they reached an OD600 » 0.5, then transferred to high aeration conditions (200 rpm). To 
support respiration, 50 µg ml-1 of hemoglobin (in 0.9 % NaCl aqueous solution) and 30 µM of 
MK-4 were added to the cultures before transfer. 
 
Table 2.1. Bacterial strains and plasmids used in this study. 
Strains Main characteristics Reference 
S. agalactiae   
NEM316 serotype III isolated from neonatal blood 
culture 
[34] 
Δndh NEM316 strain deleted of ndh gene This work 




Table 2.1 (cont.)   
Δndh/Δnox2 ∆nox2 strain deleted of ndh gene, Kmr This work 
NEMJ01  NEM316 cydA::aphA-3, Kmr [19] 
E. coli   
TG1 host strain for sequencing Lucigen 
TOP10 host strain for molecular cloning Invitrogen 
C43 (DE3) host strain for protein overproduction Avidis, France 
Plasmids   
pBR322-p+Ghost8 thermosensitive vector, Tetr [41] 
pTCV-lac shuttle vector, Eryr, Kmr [42] 
pTCV-ndhC ndh complementation plasmid This work 
pET-22b cloning vector, Ampr Novagen 
Ampr, Kmr, Tetr and Eryr indicate ampicillin, kanamycin, tetracycline and erythromycin resistance, 
respectively. 
 
Construction of ndh deficient mutant and complementation plasmid 
Primers used for constructions are listed in Table 2.2. Chromosomic DNA from S. galactiae 
strain NEM316 was used as a template to amplify by PCR a DNA fragment upstream the gene 
gbs1788 (ndh) with primer pair gbs1788F and gbs1788intR. A second fragment downstream 
gbs1788 was obtained with primer pair gbs1788intF and gbs1788R. Both fragments were fused 
by PCR with gbs1788F and gbs1788R to give the fragment Dndh, which was further cloned into 
EcoRI and BamHI sites of the thermosensitive plasmid pBR322-pGhost8 [41] to give the 
plasmid pBR322-pGhost8-Dndh. The resulting plasmid was established in E. coli strain TG1 for 




transformants were selected at 30 °C on BHI plates supplemented with 3 µg/ml tetracycline. The 
plasmid was integrated in the ndh locus when cells were grown at 37 °C (first recombination 
event) followed by growth at 30 °C for excision (second recombination event). Gene deletion 
was confirmed by PCR with primer pair gbs1788extF and gbs1788extR, designed outside of 
recombination region. In the Dndh strain, 373 out of 402 amino acid residues of NDH-2 protein 
are absent. For complementation studies, the promoter region of operon up to downstream the 
stop codon of gbs1788 was amplified by PCR with oligo pair 1788compFor and 1788compRev, 
and chromosomic DNA of a gbs1789 mutant (deletion mutant) then cloned into EcoRI/BamHI 
sites of the plasmid pTCV-lac [42]. The resulting plasmid, pTCV-ndhC, was established in E. 
coli strain TG1 for sequencing and then in the Dndh mutant. pTCV-lac was used as a control. 
The plasmids were maintained by addition of kanamycin (Km), 500 µg ml-1. 
 
Table 2.2. Primers used in this study. 
















Oxygen consumption assays and pH determination 
Oxygen consumption by S. agalactiae cells was determined at 37 °C using a dual-channel 
respirometer system (model 782, Strathkelvin Instruments). The concentration of oxygen in the 
air-saturated buffer at 37 °C was assumed to be 237.5 µM. Early stationary phase cells (8 h) were 
washed and resuspended in phosphate-buffered saline (PBS) buffer to an OD » 0.3 in a 1 ml 
chamber; oxygen consumption was followed after addition of 0.2 % glucose. Unless specified 
otherwise, the effect of different compounds on respiration was determined after 3-minute 
incubations of the cells with the drugs at 37 °C, before adding glucose.  
The pH of the media at 8 h of culture was determined using pH strips (MColorphast, Millipore).  
 
Determination of the NADH/NAD+ ratio 
Cells grown under respiration permissive or non-permissive conditions were collected at early 
stationary phase (~8 h) by centrifugation at 14,000 x g for 5 min. Pellets were washed once with 
PBS and resuspended in 400 µl of extraction buffer at an OD~30. Samples were homogenized 
twice in a FastPrep®-24 Beadbeater at 6 m/s for 45 sec cycles, with a 2 min incubation on ice in 
between. Homogenized samples were centrifuged at 4 °C in a microcentrifuge at 14,000 x g for 2 
min and intracellular levels of NADH and NAD+ were measured using the NAD/NADH 
Quantitation Kit (MAK037, Sigma-Aldrich, St. Louis, MO) according to manufacturer's 
instructions. NADH and NAD levels were normalized to mg of protein. 
 
Hemolysis assay 
Hemolytic activity using whole bacteria was assayed as described by Nizet et al. [43]. Briefly, 




under respiration permissive or non-permissive conditions were pelleted by centrifugation at 
14,000 x g, washed once with PBS, and resuspended in 1 ml of PBS with 0.2% glucose to OD~1. 
In a 96-well conical-bottom microtiter plate, 100 µl of cell suspensions, in triplicate, were 
incubated with an equal volume of 1% sheep red blood cells (RBC) in PBS-glucose. The plate 
was incubated at 37°C for 1 h and then spun down at 640 x g for 5 min to pellet unlysed RBC 
and bacteria. The supernatants were transferred to a replica 96-well plate and hemoglobin release 
was measured by recording the absorbance at 420 nm. RBC in PBS-glucose and RBC lysis with 
0.1% sodium dodecyl sulfate (SDS) were used as negative and positive controls, respectively. 
 
Animal assays 
Six-week-old female BALB/c mice were purchased from the Animal Resources Centre 
(Australia). A systemic infection model was used to assess virulence of S. agalactiae. Bacteria 
used for infection were grown statically in Todd Hewitt Broth (THB) overnight at 37°C. Mice 
were inoculated through the lateral tail vein with 2x106 bacteria in PBS (pH 7.4); inocula were 
delivered in 200 µl using 27G x 11/4 inch PrecisionGlide needles (BD) connected to 1 ml 
tuberculin syringes. At various intervals, groups of five mice were sacrificed, and blood was 
collected by cardiac puncture. Organs were collected, weighed and homogenized in PBS. The 
bacterial numbers in blood and organ homogenates were determined by plating on THB agar 
plates incubated at 37°C. Statistical analysis of bacterial counts was performed using the 
Kruskal-Wallis test, followed by Dunn’s multiple comparisons. GraphPad Prism (version 7.0b) 
software was used for all statistical analyses. A P-value < 0.05 was considered statistically 
significant. The animal experiments were repeated twice in independent experiments and were 




NDH-2 heterologous expression and purification 
S. agalactiae NDH-2 (ndh, gbs1788) open reading frame was amplified from NEM316 using 
primers listed in Table 2, and cloned into pET22-b expression plasmid, with an N-terminal 8-
histidine tag. E. coli c43 (DE3) strain, carrying the pRARE plasmid and transformed with the 
resulting plasmid, was grown under aerobic conditions (200 rpm), at 37 °C in LB medium 
supplemented with 50 µg/ml of kanamycin and 100 µg/ml of ampicillin until OD600 » 0.8, and 
expression was induced with 1 mM IPTG for 4 h. All subsequent steps were performed at 0-4°C. 
Cells were harvested at 14,000 x g for 10 min and resuspended in buffer A (50 mM sodium 
phosphate buffer pH 7.5, 300 mM NaCl), plus 5 mM MgSO4, DNAse I and protease inhibitor 
cocktail (Sigma). These were then disrupted by passing three times through a microfluidizer at a 
pressure of 80,000 psi. The resulting extracts were centrifuged at 14,000 x g for 10 min to 
remove unbroken cells, and supernatants were subject to ultracentrifugation at 230,000 x g for 4 
h to obtain membrane pellets. Membrane fractions were resuspended in buffer A plus the 
protease inhibitor cocktail and solubilized by addition of a stock solution of 20 % dodecyl-β-D-
maltoside (DDM) dropwise to a final concentration of 1 %. The suspension was incubated at 4 
°C for 1 h with mild agitation, then cleared by centrifugation at 230,000 x g for 1 h. Solubilized 
membranes were added to 5 ml of Ni-NTA resin (QIAGEN Sciences, Germantown, MD, USA) 
pre-equilibrated with buffer A plus 10 mM imidazole and 0.05 % DDM. The protein bound to 
the resin was washed with buffer A plus increasing concentrations of imidazole (10-50 mM) and 
0.05% DDM. Protein was eluted with buffer A plus 200 mM imidazole and 0.05% DDM and 
concentrated by filtration (Millipore concentrator). Imidazole was removed by a series of 
filtration and washing steps with buffer A plus 0.05 % DDM. The purified protein was stored 





Protein concentration was determined using the Pierce BCA Protein Assay Kit. Purity of the 
sample was observed by running an SDS-PAGE. FAD concentration was measured by addition 
of 5% trichloroacetic acid followed by centrifugation and determination of supernatant 
absorbance at 450 nm (e450: 11,300 mM-1 cm-1) [44]. 
 
Enzyme activity assay and determination of kinetic parameters 
The rate of NADH oxidation was determined using a UV-Vis spectrophometer (Agilent 
Technologies, model 8453) by following absorbance at 340 nm (NADH oxidation) upon addition 
of 100 µM NADH, in the presence of 2 nM enzyme and 100 µM of a quinone soluble analog. 
Assays were performed at 37°C, in buffer B (50 mM sodium phosphate buffer pH 7, 150 mM 
NaCl) plus 125 µg ml-1 of soy asolectin (Sigma) and 20 µM FAD. For determination of kinetic 
constants, 2-200 µM NADH and 2-200 µM of DMN were added to the reaction mix containing 2 
nM enzyme. Enzyme rates are expressed as a turnover number (kcat) based on moles of NADH 
oxidized per second per mol of enzyme (mol NADH s-1 mol enzyme-1). 
 
Inhibitor screening 
Isolated NDH-2 activity was tested against 1,905 compounds from two FDA-approved Drug 
Libraries (Selleck Chemicals, 1,176 compounds and NIH Clinical Collection, NCC, 729 
compounds). Enzyme activity was measured in buffer B with 125 µg ml-1 of soy asolectin, 20 
µM FAD and 50 µM of MD, in the presence and absence of 25 µM of each compound. The 
reaction was started upon addition of 100 µM NADH, after 3-minute incubation of the reaction 




further selected for determining their IC50 and GI50. IC50 refers to the concentration that causes 
50 % inhibition of enzyme activity, while GI50, to the concentration that causes 50 % inhibition 
of cell growth. The IC50 for each compound was determined by testing enzyme activity after 3-
minute incubation in the presence of different concentrations of the inhibitor, before starting the 
reaction by addition of NADH. GI50 was determined by growing the bacterial cells overnight, in 




S. agalactiae ndh encodes a highly active NDH-2 
Generally, the low amino acid sequence identity among NDH-2s makes it difficult to distinguish 
these from other small, soluble flavoenzymes [11, 45, 46].  The S. agalactiae ndh gene encodes a 
putative NDH-2 enzyme, showing relatively high identity with Staphylococcus aureus NdhC 
(42%) [47] and Caldalkalibacillus thermarum NDH-2 (41%) (Supp. Fig. 2.1) [25, 26]. The S. 
agalactiae ndh gene with an N-terminal 8xHis-tag was cloned and heterologously expressed in 
E. coli C43. S. agalactiae NDH-2 was purified and SDS-PAGE analysis shows a single band at 
the predicted molecular weight of 44 kDa (Fig. 2.2A). The UV-visible spectrum of the air-
oxidized protein shows characteristic peaks for FAD around 375 and 450 nm, with a shoulder 
around 470 nm indicating the cofactor is in an apolar environment [48] (Fig. 2.2B). The FAD 
cofactor remains in solution after precipitation of the protein with 5% tricholoracetic acid, 
demonstrating the flavin is non-covalently bound [44].  Quantitation of the extracted flavin was 
calculated to be 0.25 mol FAD/mol protein. Substoichiometric flavin content is often observed 




sub-stoichiometric amounts of FAD, assays were performed in presence of 20 µM FAD. Upon 
addition of the flavin, a 10-fold increase in activity was observed. All results reported were 
performed with 20 µM FAD in the assay buffer. 
Although lacking any transmembrane spanning elements, NDH-2 is a membrane bound 
protein that, upon isolation, requires the presence of detergent to remain in solution. Optimal 
enzyme activity and stability also required 150-300 mM NaCl and pH 7. NADH:quinone 
oxidoreductase activity was tested in the presence of NADH and different soluble quinone 
analogs (Fig. 2.2C). S. agalactiae endogenous electron acceptor for NDH-2 is DMK-10 [21], a 
naphthoquinone, but the pure enzyme is also active with ubiquinones (Fig. 2.2 C and E). With 
2,3-dimethyl-1,4-naphthoquinone (DMN), the soluble menaquinone analogue most similar to the 
natural electron acceptor in S. agalactiae membranes, the turnover number is about 800 
NADH/s-1 and the KM values for DMN and NADH are 11 µM and 28 µM, respectively. The 
isolated S. agalactiae NDH-2 does not react directly with O2 in the presence of NADH, unlike 






Figure 2.2. The isolated enzyme from S. agalactiae is a highly active NDH-2 (A) SDS-PAGE of ~5 µg 
of isolated protein. (B) UV-visible spectrum of the flavin. (C) Enzyme activity was measured with 
different soluble quinone analogs. Data are expressed as average ± SD of three independent experiments. 
Q1: Ubiquinone-1; Q2: Ubiquinone-2; DUQ: Decylubiquinone; DQ: Duroquinone; MD: Menadione; 
DMN: 2,3-Dimethyl-1,4-naphthoquinone. 100% activity corresponds to 4,190 NADH sec-1 observed in 
the presence of Q1. (D) Turnover number (kcat) and affinity (KM) for its substrates were determined. Data 
are expressed as average ± SD of three independent experiments. (E) Core structures for benzoquinones 
(Q1, Q2, DUQ and DQ) and naphthoquinones (MD and DMN). 
 
NDH-2 is the only entry point for electrons into the respiratory chain of S. agalactiae 
An ndh deletion mutant was constructed to characterize the role of NDH-2 in the S. agalactiae 
respiratory metabolism. Since both aerobic respiration and Nox-2 are involved in oxygen 
reduction to water and regeneration of NAD+ [38] (Fig. 2.1), a double Δndh/Δnox2 strain was 
also constructed to characterize the effect on metabolism and oxygen tolerance. As a control, a 
previously studied single nox2 knockout strain [38] was also examined. 
The WT, Δndh, Dnox2 and Δndh/Δnox2 strains were grown aerobically in the presence of 
externally added heme and quinone (referred as respiration permissive condition) and in the 
absence of heme and quinone (referred as respiration non-permissive condition) (Fig. 2.3). When 
the WT or Dnox2 strain is grown aerobically in the presence of external heme and quinone, 




metabolic shift favoring mixed-acid fermentation, reduced lactate formation and hence, a smaller 
pH drop in the medium [19, 51]. In contrast, the Δndh strain does not show any difference in 
growth rate or pH drop (Fig. 2.3B), likely due to an increase in consumption of glucose that 
results in a higher production of lactate (which has a lower pKa) observed under non-permissive 
conditions. This is to overcome the lower energetic efficiency derived from homolactic 
fermentation. The growth behavior and pH of the Δndh strain are restored to that of the WT 
strain if the deletion is complemented by a plasmid carrying the ndh gene under the control of its 
own promoter (Supp. Fig. 2.2), indicating the observed effect is in fact due to NDH-2 activity. 
Similar results are observed for the Δndh/Δnox2 strain (Fig. 2.3D). 
 
Figure 2.3. The NDH-2 deficient strain shows a non-respiratory phenotype. Growth curves and pH of 
the media at 8 h of culture are shown for (A) WT, (B) Dndh, (C) Dnox2 and (D) Dndh/Dnox2 strains. Cells 
were grown under respiration permissive (P, white circles/bars) and non-permissive conditions (NP, black  
circles/bars). Growth curves are representative of at least 3 independent experiments. pH data are plotted 





The effect of the deletions on oxygen utilization was tested for cells grown under either 
respiration permissive and non-permissive conditions (Fig. 2.4A). Both respiration (NDH-2/cyt 
bd) and Nox-2 activity result in oxygen utilization. In the double deletion Δndh/Δnox2 strain, no 
oxygen utilization is observed under any circumstances, suggesting that the elimination of NDH-
2 results in the complete absence of respiration.  
 
 
Figure 2.4. NDH-2 is important for respiration and for maintenance of NADH/NAD+ redox balance. 
Cells were grown under respiration permissive (white bars) or non-permissive conditions (black bars) and 
harvested in early stationary phase. (A) Oxygen consumption assays were normalized to OD600 = 0.3 and 
started by the addition of 0.2% glucose. (B) NADH/NAD+ ratio was determined for the WT and isogenic 
mutant strains. Data are plotted as the average ± SD of three independent experiments. (A) ** p <0.005 
via two-way ANOVA with Tukey’s post-test for the indicated comparisons. No significative difference 
was observed, between non-permissive/permissive conditions, for Dndh or Dndh/Dnox2. (B) *p <0.05, 
**p<0.005, ***p<0.001 via two-way ANOVA with Dunnett’s post-test when compared to wild type non-
permissive.  
 
When grown in the absence of heme and quinone, the WT and Δndh strains utilize 
oxygen at the same rate, since Nox-2 is the only enzyme contributing to the measured depletion 
of O2. In the presence of heme and quinone, the WT strain has substantially more activity than 
the Δndh strain, since the WT strain is able to respire while the Δndh strain cannot. All of the 
observed oxygen utilization of the Dnox2 strain, grown with heme and quinone, is due to NDH-




Dnox2 strains, the capacity for O2 utilization by the respiratory chain can be estimated to be 
about 6-fold higher than that for Nox-2 (Fig. 2.4A). 
Lastly, the importance of aerobic respiration and Nox-2 in NADH reoxidation was 
evaluated in cells grown under respiration permissive or non-permissive conditions (Fig 2.4B). 
When grown under permissive conditions, the NADH/NAD+ ratio did not show significant 
differences in the Δndh and Dnox2 strains. However, both the Δndh/Δnox2 strain and the Δnox2 
strain, when grown under non-permissive conditions, show a drastic increase in NADH and 
NADH/NAD+ ratio compared to the wild type. This suggests that NDH-2 (respiration) and Nox-
2, are the major routes for NAD+ recycling and these observations support the previously 
proposed role for respiration in fatty acid biosynthesis [38].   
 
NDH-2 is important for S. agalactiae virulence 
Due to the essential role of NDH-2 in S. agalatiae respiration, we investigated its contribution to 
the development of invasive disease. The bacterial burdens or fitness of the S. agalactiae WT 
and mutant strains in different organs were determined after 24 h, 48 h and 72 h post-infection 
(Fig. 2.5).  Infection assays using S. agalactiae Δndh and double Δndh/Δnox2 strains revealed 
significant attenuation in heart and kidney colonization compared to WT (Fig. 2.5 A and B). The 
Δnox2 strain is significantly attenuated in heart and spleen compared to WT (Fig. 2.5 A and C) 
as reported in previous studies [38]. Unexpectedly, no pronounced phenotype is seen in any 
organ with the double Δndh/Δnox2 strain, although this double mutant does not tolerate oxygen 
well. In an effort to explain this, we investigated the hemolytic activity of these knockout strains 
(Fig. 6). The cell surface-associated β-hemolysin/cytolysin of S. agalactiae is a non-




major virulence factor is encoded by the cylE gene in the cyl locus, a unique 12-gene operon 
involved in fatty acid biosynthesis [54] that is expressed by most GBS strains. This virulence 
factor has a proapoptotic, proinflammatory and cytotoxic effects and is necessary for full S. 
agalactiae virulence in multiple in vivo systems [55]. Furthermore, the hemolytic pigment has 
been shown to protect cells against a panel of stresses [52, 56]. Remarkably, increased hemolysis 
was observed for the double mutant compared to the Dndh strain (Fig. 2.6), which correlates with 
the dramatic increase seen for the NADH/NAD+ ratio (Fig. 2.4B). Thus, this could contribute to 
the rescue effect observed during infection.  Consistent with this interpretation, hemolysis is 
restored to WT levels upon addition of 0.1 % Tween 80 to the cell cultures, effectively providing 
fatty acids to the cells (Fig. 2.6).  
 
 
Figure 2.5. The Dndh, Dnox2 and DcydA strains are attenuated for virulence in heart, kidney and 
spleen. Mice were infected with 2x106 CFU of S. agalactiae and bacteria were counted at 24, 48 and 72 h 
post-infection in (A) heart, (B) kidney and (C) spleen.  Bacterial fitness of mutants is shown as ratio of 
the number (CFU/gram) of mutant to WT bacteria in log10 mutant:WT. *P<0.05, **P<0.01, 
****P<0.0001 (mutant:WT; Kruskal Wallis test, followed by Dunn’s multiple comparisons). # denotes a 






Figure 2.6. Hemolytic activity correlates with NADH/NAD+ ratios. Cells were grown under respiration 
permissive (white bars) or non-permissive conditions (black bars) until early stationary phase, then 
washed and incubated with RBC for 1 h. Dark and light grey bars represent respiration non-permissive 
and permissive growth, respectively, with 0.1% tween 80 added to the media. Data are plotted as the 
average ± SEM of three independent experiments. * p <0.0001 via two-way ANOVA with Dunnet’s post-
test when compared to wild type non-permissive. 
 
Among the mutants tested the strain lacking cyt bd (ΔcydA) has been previously shown to 
result in changes in organ colonization in mice [22]. The cydA knockout strain, used here as a 
control for S. agalactiae attenuation in the model of systemic infection, is significantly 
attenuated in heart, kidney, spleen (Fig. 2.5) and liver (Supp. Fig. 2.3), and its attenuation 
approaches statistical significance in blood (P=0.08) (Supp. Fig. 2.3), findings consistent with 
what has been previously observed [22]. None of the mutants are significantly attenuated in 
blood, liver or brain colonization (Supp. Fig. 2.3 A-C). These data support the conclusion that 
respiration is important for virulence in S. agalactiae [19, 22], and shows, furthermore that 
NDH-2 contributes to virulence.  
 
Inhibitors of S. agalactiae NDH-2 are potential leads against GBS 
Since this work demonstrates that NDH-2 is essential for respiration in S. agalactiae as well as 
important for virulence, inhibitors of the isolated enzyme were obtained and then tested as 




colorimetrically in the presence of NADH and menadione (MD), a commercially available 
soluble analogue of menaquinone. Two libraries of FDA-approved drugs were screened (about 
2,000 compounds) using 25 µM of each compound to test for inhibitors of the pure enzyme. Nine 
compounds inhibited at least 80% of enzymatic activity: alexidine, candesartan, caspofungin, 
closantel, hexachlorophene, isoquercetin, pramoxine, triclabendazole and zafirlukast. Except for 
hexachlorophene, a relatively toxic disinfectant, all other compounds were tested against whole 
cells growing under respiration permissive conditions, and five of these showed an inhibitory 
effect on cell growth (Table 2.3). 
 
Table 2.3. FDA-approved compounds that inhibit NDH-2 activity and S. agalactiae growth 
in vitro. 
Compound IC50 (µM) GI50 (µM) Common use 
Alexidine 16.79 ± 1.26  2.70 ± 0.51 antiseptic 
Caspofungin 15.23 ± 2.33 41.03 ± 2.62 antifungal 
Closantel  5.34 ± 0.65  0.25 ± 0.04 antihelmintic (vet) 
Triclabendazole  0.14 ± 0.02 15.30 ± 1.92 antihelmintic 
Zafirlukast  0.83 ± 0.07   6.07 ± 0.10 asthma treatment 
Cells were grown under respiration permissive conditions. 
 
Although candesartan, isoquercetin and pramoxine are able to inhibit the purified enzyme 
in vitro, they show no effect on cell growth.  On the other hand, alexidine and closantel inhibit 
cell growth at concentrations much lower than those required for NDH-2 inhibition, suggesting 
other targets might be responsible for their effect in whole cells. This is not surprising since both 




strong uncoupling [58]. Finally, caspofungin, triclabendazole and zafirlukast not only show 
NDH-2 inhibition in the low micromolar and even nanomolar range but are also able to inhibit 
cell growth at low micromolar concentrations (Table 2.3).  
Additional assays followed oxygen consumption of WT cells (grown with heme and 
quinone) in the presence of different concentrations of caspofungin, triclabendazole or 
zafirlukast. From these compounds, only zafirlukast shows a dose-dependent linear decline in 
respiration, with 90% inhibition at 7.5 µM (Fig. 2.7A). In addition, the Δnox2 strain was grown 
overnight with and without subinhibitory concentrations of zafirlukast (~ GI50), and both growth 
and respiration were examined after overnight incubation. The Δnox2 strain grown in the 
presence of zafirlukast does not exhibit enhanced growth under respiration permissive conditions 
compared to non-permissive conditions. This indicates that the bacterial growth supported by the 
activity of the electron transport chain is substantially reduced in the presence of zafirlukast (Fig. 
2.7B).  Not all of the NDH-2 activity was eliminated since the cells were grown with a 
concentration of zafirlukast that does not completely inhibit the enzyme. This is shown in Fig. 
2.7C where the oxygen utilization, which must be due to respiration in the Δnox2 strain, is 
substantially lower than when the cells are grown in the absence of zafirlukast, but not as low as 
when cells are grown in the absence of heme and quinone. In sum, the data show that zafirlukast 







Figure 2.7. Zafirlukast inhibits S. agalactiae respiration. Cells were grown until early stationary phase 
(8 h) and (A) percentage of respiration was calculated after addition of different concentrations of 
zafirlukast. Percentage of respiration corresponds to the difference in oxygen consumption of cells grown 
under respiration permissive (P) minus non-permissive conditions (NP). (B) Overnight growth and (C) 
oxygen consumption of Dnox2 strain in the absence or presence of 7.5 µM Zafirlukast (Z). Data are 
plotted as the average ± SD of three independent experiments. (B and C) * p<0.05, ** p<0.005 and *** 
p<0.001 via two-way ANOVA with Tukey’s post-test for the indicated comparisons. No significative 
difference was observed between NP, NP+Z and P+Z. 
 
2.4. DISCUSSION 
S. agalactiae can cause invasive disease in newborns leading to meningitis and septicemia and is 




organism capable of metabolizing a wide variety of substrates, however an obligate commensal, 
auxotrophic for several amino acids and vitamins [16, 34]. Although it used to be considered an 
aerotolerant organism, S. agalactiae was found over 10 years ago to perform aerobic respiration 
in the presence of external sources of heme and quinone [19]. Aerobic respiration consists in the 
transport of electrons through a series of redox components, from a metabolic reductant (e.g., 
NADH) and terminating in the reduction of oxygen to water by a terminal oxygen reductase. 
Importantly, respiration is linked to the generation of PMF and ATP synthesis via Ack and 
possibly oxidative phosphorylation (Fig. 2.1C).  
S. agalactiae has a two-enzyme respiratory chain: S. agalactiae has a single oxygen 
reductase, cyt bd. The first conclusion of the current work is that there is only one enzyme, 
NDH-2, that provides electrons to the respiratory chain of this organism. Both NDH-2 and cyt bd 
are encoded by genes (ndh and cydAB, respectively) within the same operon. Although single 
subunit respiratory flavoenzymes are often missannotated [59], an exhaustive search of the 
genome of S. agalactiae shows no other genes for any additional respiratory enzymes, like 
glycerol-3-P dehydrogenase, pyruvate oxidase or membrane-bound succinate, lactate or malate 
dehydrogenases. A glp operon for glycerol metabolism is present however, glycerol phosphate 
dehydrogenase (glpD) is replaced by a glycerol phosphate oxidase (glpO), as in other organisms 
that do not synthesize heme. This latter enzyme is soluble and reduces oxygen to hydrogen 
peroxide instead of reducing quinone [60]. Also, whereas some bacterial pathogens (e.g., S. 
aureus) have two different NDH-2 enzymes [47], S. agalactiae has only one and there is no other 
type of respiratory NADH dehydrogenase, such as complex I (NDH-1) or the sodium pumping 
NDH (Nqr) [4]. Thus, unlike most other bacteria, the electron transport chain of S. agalactiae is 




The ndh gene encodes an authentic NDH-2: The S. agalactiae ndh gene was cloned and 
expressed in E. coli and the purified recombinant protein was shown to be an NADH:quinone 
oxidoreductase.  The isolated, recombinant S. agalactiae NDH-2, which has an amino acid 
sequence identity of 42% with S. aureus NdhC, has a high kcat (~ 800 NADH s−1) that is similar 
to that of S. aureus NdhC (~ 1,500 NADH s-1) [47].  These kcat values are substantially higher 
than those reported for NDH-2s from other organisms, including the NDH-2s from E. coli ,with a 
kcat of ~ 18 NADH s−1 [61], M. tuberculosis, with a kcat of ~ 10 NADH s−1 [62], Bacillus 
pseudofirmus, with a kcat of ~ 39 NADH s−1 [63], B. subtilis, with a kcat of ~ 20 NADH s-1 [64] 
and C. glutamicum, with a kcat of ~ 213 NADH s−1 [50]. The high activities obtained for the 
enzymes from S. agalactiae and S. aureus are most likely due to the presence of phospholipids 
and FAD in the reaction buffer of our assays. The S. agalactiae NDH-2 has a lower KM for 
NADH (11 µM) compared to those of other previously characterized NDH-2s from bacteria. For 
example, the apparent KM values for NADH of the NDH-2 from E. coli is 34 µM [61], from B. 
subtilis , 60 µM [64], from B. pseudofirmus,  114 µM [63] and from S. aureus, 35 µM (NdhC) 
and 154 µM (NdhF) [47].  
Multiple advantages of utilizing aerobic respiration: S. agalactiae grows well by 
utilizing a variety of fermentation strategies (Fig. 1) but the operon encoding NDH-2 and cyt bd 
is expressed constitutively so the cells can very rapidly switch to respiratory growth [19] in the 
presence of O2 after taking up quinone and heme form the environment [21, 65]. Certainly, a 
major advantage of respiratory growth is a higher bioenergetics capacity via Ack and possibly 
oxidative phosphorylation. In addition to enhanced growth efficiency, respiration also serves for 
(i) the reduction of the intracellular and local concentration of O2 and to combat oxygen toxicity; 




generation of the PMF required for powering transporters and essential efflux pumps like PefAB 
[28, 66] (iv) contributing to resistance against environmental acid stress [20, 67]; and (v) the 
production of virulence factors, e.g., respiration is required for nuclease production [68]. 
Respiration is linked to virulence and organ colonization: The different stimuli found in 
the growth environment, including the carbon source(s), concentration of O2, and the availability 
of external heme and quinone, determine the metabolic pathways utilized to optimize the growth 
and survival of S. agalactiae. The growth conditions vary significantly when comparing in vitro 
batch growth to in vivo growth in a host animal, or when comparing the in vivo growth in 
different organs. The combination of metabolic pathways utilized by S. agalactiae must 
simultaneously generate ATP, maintain the PMF, reduce O2 levels if it is present and maintain 
the recycling of NADH through NAD+. Since the metabolic strategies used by S. agalactiae can 
be very different in each organ in an infected animal, it is reasonable that mutations that 
incapacitate respiration will have different effects for organ colonization depending on the organ. 
Based on studies with a cyt bd oxidase deletion mutant, S. agalactiae respiration has been 
previously linked to virulence and colonization of blood-rich organs [19, 22]. It is shown in the 
current work that the deletion of the gene encoding NDH-2 eliminates in vitro respiration and 
also results in attenuation of organ colonization in a mouse model for systemic infection.  The 
strongest attenuation from the ndh deletion is in heart and kidney. The apparent significance of 
respiration for kidney infection may be useful considering the importance of S. agalactiae in 
urinary tract infections in the elderly [18]. Moreover, S. agalactiae is able to synthetize its own 
DMK-10 starting from 1,4-DHNA (dihydroxy-2-naphthoic acid) or short chain quinones, such as 
MK-4 [21], which can be found in high concentrations in the kidney [69]. An unexpected finding 




highly attenuated Dndh strain (Fig. 5B). This may be related to the increased hemolysis observed 
for the double mutant strain compared to the Dndh strain (Fig. 6). The double Dndh/Dnox2 strain 
is highly impaired in NADH oxidation to NAD+ (Fig. 4B) and the deficiency of NAD+ likely 
results in impaired fatty acid biosynthesis [38]. The increased hemolysis observed in the double-
knockout strain (Fig. 6), may be the response of S. agalactiae to obtain fatty acids from 
surrounding host cells [70].  
It is noteworthy that the Dndh strain is much more impaired in colonization in the kidney 
than is the DcydA strain, since both of these mutants disrupt respiration. One possible explanation 
is that the presence of a heme-containing enzyme in the membrane (cyt bd) in the Dndh strain 
makes the bacterial cells more susceptible to the strong oxidative stress displayed by the kidney 
during sepsis [71]. Alternatively, higher levels of reduced menaquinone in the DcydA strain 
could lead to production of small amounts of intracellular ROS, stimulating a response against 
oxidative stress through PerR [72, 73], enhancing survival of the strain in the kidney. The precise 
molecular explanation for the organ-specific effects of the mutants on colonization will require 
further studies. 
Inhibitors of S. agalactiae NDH-2: Screening for inhibitors against the purified S. 
agalactiae NDH-2 was done in the presence of lipids to mimic the hydrophobic environment of 
the enzyme in situ. Although several compounds from libraries of FDA-approved drugs were 
found to inhibit the enzyme in vitro, only zafirlukast also inhibits respiration in intact cells in a 
way that suggests NDH-2 is the likely target in vivo. However, it is possible that this compound 
has other targets in S. agalactiae. Zafirlukast is a cysteinyl leukotriene receptor antagonist, 
currently used for the prophylaxis and chronic treatment of asthma [74]. It is a commercially 




bactericidal activity against M. tuberculosis by inhibiting the complex formation between Lsr2 (a 
nucleoid-associated protein) and DNA [76]. Zafirlukast also has been demonstrated to have 
antibacterial and antibiofilm activity against the non-respiratory oral pathogens Porphyromonas 
gingivalis and Streptococcus mutans [77].  
It is worth mentioning that despite its high similarity with S. aureus NdhC, S. agalactiae 
NDH-2 is not inhibited by trifluoperazine or thioridazine, phenothiazines which both show a 
strong inhibitory effect on the S. aureus NdhC [47]. These data demonstrate that the NDH-2 
enzymes from different organisms, though apparently very similar, can have different inhibition 
profiles with drugs. These small enzymes, with binding sites for both NADH and quinol, appear 
to be susceptible to inhibitors that do not bind at the substrate binding sites but, rather, to 
allosteric sites [62]. Although the substrate binding sites may be conserved among different 
NDH-2s, inhibitor-binding regions may differ greatly. In any event, zafirlukast may be useful as 
a laboratory tool to inhibit respiration in S. agalactiae and, since it has few side effects [78] 
might be considered a lead compound for therapeutics. 
 





Supplemenatry Figure 2.1. S. agalatiae amino acid sequence shows high identity with C. thermarum 
and S. aureus NDH-2s. Identical residues among the three sequences are shaded in red. Figure was made 
using ESPript [79]. 
 
 
Supplementary Figure 2.2. The Δndh growth phenotype is complemented by a plasmid-encoded 
copy of ndh. (A) Final growth and (B) pH at 8 h of culture, under respiration permissive (white bars) or 
non-permissive conditions (black bars), for WT and Δndh strains carrying the empty (p) or ndh-
expressing vector (p-ndh). Data are plotted as the average ± SD of three independent experiments. * p = 





Supplementary Figure 2.3. The Dndh, Dnox2 and DcydA strains are not attenuated for virulence in 
blood, liver nor brain. Mice were infected with 2x106 CFU S. agalactiae and bacteria were enumerated 
at 24, 48 and 72 h post-infection in (A) blood, (B) liver and (C) brain. Bacterial fitness of mutants is 
shown as ratio of the number (CFU/gram) of mutant to WT bacteria in log10 mutant:WT. *p<0.05, 
**p<0.01, ****p<0.0001 (mutant:WT; Kruskal Wallis test, followed by Dunn’s multiple comparisons). # 





3. CHARACTERIZATION OF THE TYPE III SULFIDE:QUINONE 
OXIDOREDUCTASE FROM CALDIVIRGA MAQUILINGENSIS AND ITS 
MEMBRANE BINDING 
*Adapted with permission of the authors. Copyright belongs to Andrea M. Lencina, Ziqiao Ding, Lici A. Schurig-
Briccio and Robert B. Gennis.  
Biochim. Biophys. Acta. 2013 Mar;1827(3):266-75. doi: 10.1016/j.bbabio.2012.10.010. 
 
3.1. INTRODUCTION 
Sulfide (S2-, HS- and H2S) is found in marine and soil environments and is endogenously 
produced by eukaryotic and prokaryotic cells as a product of cysteine catabolism. Although 
highly toxic, particularly as an inhibitor of aerobic respiration (via the terminal oxidases), sulfide 
is an important source of electrons in prokaryotes that can grow under phototrophic or 
chemotrophic conditions [80-84], as well as in mitochondria [85, 86]. In addition, sulfide (H2S) 
has been shown to be important in some bacteria as a universal defense against antibiotics [87] 
and as an endogenous gaseous signaling molecule [88, 89], and as a neuromodulator [90] in 
mammals.  
A key enzyme in the maintenance of sulfide homeostasis and bioenergetics is sulfide:quinone 
oxidoreductase (SQR), which is present in many eubacteria, archaea and in the mitochondria of 
eukaryotic cells.  SQR catalyzes the two-electron oxidation of sulfide to elemental sulfur and 
reduces quinone in the membrane.  The sulfur is released either as a highly insoluble octameric 
ring, S8, or as short chains of polysulfide (HS-(Sn)-SH), which results from the reaction of 
elemental sulfur with H2S. The resulting sulfur is stored in cytoplasmic or periplasmic globules 




exemplified by Chlorobaculum tepidum, a green sulfur bacterium, which encodes at least three 
SQRs or SQR-like proteins in its genome [92-94]. 
SQR proteins are single-subunit flavoproteins with a molecular mass of about 50 kDa, 
associated with the prokaryotic cytoplasmic membrane or the mitochondrial inner membrane. It 
has been suggested that there is a single phylogenetic origin of all SQRs [95].  X-ray structures 
are available for SQRs from Aquifex aeolicus (a hyperthermophilic bacterium) [92, 96, 97], 
Acidithiobacillus ferrooxidans (an acidophilic and chemolithotrophic bacterium) [98, 99] and 
Acidianus ambivalens (a thermoacidophilic archaeon of the order Sulfolobales)[11]. None of 
these enzymes contains a transmembrane helical anchor and they are designated as monotopic 
membrane proteins, associated with one leaflet of the membrane bilayer [96].  Monotopic 
membrane proteins are generally attached to the surface of the membrane by interactions via 
basic residues with the phospholipid headgroups along with hydrophobic interactions with the 
bilayer core [100].  The extent of penetration into the membrane bilayer differs for different 
monotopic proteins though the amount of experimental data is quite limited [100].  Generally, 
SQRs have two short amphiphilic helices at their C-terminus and it is proposed that the 
membrane attachment is via one or both of these helices [97]. 
A structure-based classification system of SQRs based on sequence fingerprints has been 
proposed [92], which results in the definition of six groups within the SQR family (I, II, III, IV, 
V and VI).  These groups largely correspond to a phylogenetically defined nomenclature that 
was recently suggested [84] : Type I = SqrA; Type II = SqrB; Type III = SqrC; Type IV = SqrD 
plus SqrX; Type V = SqrE and Type VI = SqrF. The greatest amount of information is available 
for the Type I SQRs (SqrA), which includes those from A. aeolicus and A. ferrooxidans, for 




characterized using site-directed mutagenesis [101]. The structure of a truncated version of a 
Type V/SqrE SQR, from A. ambivalens, has also been determined [11]. The least amount of 
information is available for the putative SQRs of Type III/SqrC.  Whereas representatives of 
each of the other five SQRs have been demonstrated to have sulfide:quinone oxidoreductase 
activity, no Type III SQR has been shown to have this enzymatic activity.  Genes encoding Type 
III SQR genes are found in both archaea (e.g., Vulcanisaeta distribute and Pyrobaculum 
aerophilum) and in bacteria (e.g., Magnetospirillum magnetotaticum and Chlorobaculum 
tepidum).   
Fig. 3.1 compares the sequences of several Type I and Type III SQRs, along with the 
sequence of the Type V SQR from A. ambivalens.  Among the features [92] that distinguish the 
Type III SQRs are 1) the absence of a cysteine residue which, in Type I SQRs is implicated in 
flavin binding (C124 in the A. aeolicus SQR); 2) the absence of two “capping loops” (designated 
loop 1 and loop 2), one of which (loop 2) is present in the Type I SQRs and the other in Type V 
SQRs; 3) absence of an elongated C-terminus, which characterizes the Type I SQRs. 
Figure 3.1 
             ....|....| ....|....| ....|....| ....|....| ....|....|  
                      10         20         30         40         50              
A.a.         ---MAKHVVV IGGGVGGIAT AYNLRNLMPD L--KITLISD RPYFGFTPAF  
A.f.         ----MAHVVI LGAGTGGMPA AYEMKEALGS GH-EVTLISA NDYFQFVPSN  
R.c.         ----MAHIVV LGAGLGGAIM AYELREQVRK ED-KVTVITK DPMYHFVPSN  
A.h.         ----MAHIVI VGGGFGGLSA AYELKHLLHG KH-KITLISD ETTFTFIPSL  
O.l.         ----MAHVAV IGAGLAGLPT AYELRHILPR QH-RVTLISD KPNFTFTPSL  
C.m.         MSDGRRRVII IGGGTGGLVL A----NRLPK DEFEVTVIDK QPYNYFLPWL  
V.d.         MSTVKRRVVI IGGGTGGAML A----NRLPK DEFEVTIIDK QPYNHFWPWL  
A.am.        ----MTKVLV LGGRFGALTA AYTLKRLVGS KA-DVKVINK SRFSYFRPAL  
 
 
             ....|....| ....|....| ....|....| ....|....| ....|....|  
                      60         70         80         90        100             
A.a.         PHLAMGWRKF EDISVPLAPL LPKFNIEFIN EKAESIDPDA NTV----TTQ  
A.f.         PWVGVGWKER DDIAFPIRHY VERKGIHFIA QSAEQIDAEA QNI----TLA  
R.c.         PWVAVGWRDR KEITVDLAPT MARKNIDFIP VAAKRLHPAE NRV----ELE  
A.h.         PWVAFNLRRL EDVQLPLAPL LARQGINWQH GRVTGLDPNQ KRV----SVG  
O.l.         PWVAFDLTPL ERVQLDVGKL LKGRNIDWIH GKVNHIDPEN KTL-----VA  




Figure 3.1 (cont.) 
V.d.         LYIAFR-GSR RPIKREIRSV LKPW-VNFIQ SGVKAVNLQD RYV----ELD  
A.am.        PHVAIGVRDV DELKVDLSEA LPEKGIQFQE GTVEKIDAKS SMVYYTKPDG  
 
 
             ....|....| ....|....| ....|....| ....|....| ....|....|  
                     110        120        130        140        150         
A.a.         SGKKIEYDYL VIATGPKLVF ----GAEGQE ENST-SICTA EHALETQKKL  
A.f.         DGNTVHYDYL MIATGPKLAF ENVPGSDP-H EGPVQSICTV DHAERAFAEY  
R.c.         NGQSVSYDQI VIATGPELAF DEIEGFGP-- EGHTQSICHI DHAEAAGAAF  
A.h.         EDITFDYDYL VITTGASLAY HLMSGLGP-E EGYTQSVCNA HHAEMARDAW  
O.l.         GEQTLEYDYV VVATGPELAT DAIAGLGP-E NGYTQSVCNP HHALMAKEAW  
C.m.         NGKRLSYDYL VVATGATVDY SKVPGLDQLT ELYGD--YHS SEENAWRVWR  
V.d.         NGKRLEYDYV VIATGATVDY SRIPGLDKVT EMFGN--YHS NEENAWRVWQ  
A.am.        SMAEEEYDYV IVGIGAHLAT ELVKGWDK-- --YGYSVCEP EFATKLREKL  
 
 
             ....|....| ....|....| ....|....| ....|....| ....|....|  
                     160        170        180        190        200         
A.a.         QELYA-NPGP VVIGAIP--- ---------- -----GV-SC FGPAYEFALM  
A.f.         QALLR-EPGP IVIGAMA--- ---------- -----GA-SC FGPAYEYAMI  
R.c.         DRFCE-NPGP IIIGAAQ--- ---------- -----GA-SC FGPAYEFTFI  
A.h.         DEFLE-NPGP LLVGAVP--- ---------- -----GA-SC MGPAYEFALL  
O.l.         QKFLQ-DPGP LVVGAVP--- ---------- -----GA-SC FGPAYEFALL  
C.m.         TVNSINEGTL AFILSY---- ---------- -----ERYRC PPSPLEGVLL  
V.d.         TLNSMREGTL AIILAP---- ---------- -----GAYRC PPSPLEGTFL  
A.am.        ESF---QGGN IAIGSGPFYQ GHNPKPKVPE NFVPNADSAC EGPVFEMSLM  
 
                                      1st loop 
             ....|....| ....|....| ....|....| ....|....| ....|....|  
                     210        220        230        240        250         
A.a.         LHYELKKRGI RYKVP-MTFI T--SEPYLGH FGVGGIGASK RLVEDLFAER  
A.f.         VASDLKKRGM RDKIPSFTFI T--SEPYIGH LGIQGVGDSK GILTKGLKEE  
R.c.         LDTALRKRKI RDKVP-MTFV T--SEPYVGH LGLDGVGDTK GLLEGNLRDK  
A.h.         ADYALRQEGK RDQVP-ITFI S--PEPYLGH LGIGGMANSG KLVTELMKQR  
O.l.         ADYVLRRKGM RDRVP-ITFV T--PEPYVGH LGIGGMANSA ELVTDLLENK  
C.m.         ADELLRRRGV RDRVN-LVYA TSYPRPYPAE -------PMN EVVEPILKER  
V.d.         AEEFFRKRGL RDKVR-IVFA TFYPRPYPAE -------PMN ELIEPLLKER  
A.am.        LHGYFKKKGM LDKVH-VTVF S--PGEYLSD LS----PNSR KAVASIYNQL  
 
 
             ....|....| ....|....| ....|....| ....|....| ....|....|  
                     260        270        280        290        300         
A.a.         NIDWIANVAV KAIEPDKVIY EDLN--GNTH ---EVPAKFT MFMPSFQGPE  
A.f.         GIEAYTNCKV TKVEDNKMYV TQVDEKGETI KEMVLPVKFG MMIPAFKGVP  
R.c.         HIKWMTSTRI KRVEPGKMVV EEVTEDGTVK PEKELPFGYA MMLPAFRGIK  
A.h.         NIDWVENAEI AEIKEDHVKL TD----GR-- ---EFPFNYS MFLPPFRGAQ  
O.l.         GIRVLPNTAV KEIHPEHMDL DS----GE-- ---QLPFKYA MLLPPFRGPA  
C.m.         GIETVTFFTL DHVDAKDGVA YSLE--GE-- ---ELKFNAA IVIPPHVGVG  
V.d.         GIEYITFYTL DRIDPEKRVA YSME--GE-- ---ELKFDAA IVIPPHVGVD  
A.am.        GIKLVHNFKI KEIREHEIVD EK----GN-- ---TIPADIT ILLPPYTGNP  
 
 
             ....|....| ....|....| ....|....| ....|....| ....|....|  
                     310        320        330        340        350         
A.a.         VVASAGDKVA NPANKMVIVN RCFQNPTYKN IFGVGVVTAI PPIEKTPIPT  




Figure 3.1 (cont.) 
R.c.         ALMGIEG-LV NPRGFVIVDQ -HQQNPTFKN VFAVGVCVAI PPVGPTPVPC  
A.h.         FLKEVPG-LT DEKGFLPVLD -TYQHPDYPS IYSAGVITQL AAPEETEVPL  
O.l.         FLREAPE-LT NPKGFVPVTN -TYQHPKYES VYSAGVIVEI NPPEKTPLPV  
C.m.         -IKYNPDNVL DQDGFVLADN ATNRIKGFDD AFVIGDASAL P---------  
V.d.         -IKYVPEDVL DSDRFVQADK FTNRVKGFDD AFVIGDASAL P---------  
A.am.        ALKNSTPDLV DDGGFIPTDL -NMVSIKYDN VYAVGDANSM T---------  
 
                                                           2nd loop 
             ....|....| ....|....| ....|....| ....|....| ....|....|  
                     360        370        380        390        400         
A.a.         GVPKTGMMIE QMAMAVAHNI VNDIR-NNPD KYAPRLSAIC IADFGEDA-G  
A.f.         GAPKTGYMIE SMVSAAVHNI KADLEGRKGE QTMGTWNAVC FADMGDRG-A  
R.c.         GVPKTGFMIE SMVTATAHNI GRIVRGLEPD EV-GSWNAVC LADFGDKG-I  
A.h.         GAPKTGQMTE SMAMAVAHNI ARELGEINAR PVKPSLEAIC MADFGDTG-I  
O.l.         GVPKTGQMTE AMGMAAAHNI AIKLGVSKAK PVQPTLEAIC IADFGDTG-I  
C.m.         -VAKTGVTAH LQATVVAKIL TGEDACNTGR TH-------C PFDMGYGL-A  
V.d.         -VAKTGVTAH LQAGVVARIL QGEDARNTGR TN-------C PFDVGYGL-G  
A.am.        -VPKLGYLAV MTGRIAAQHL ANRLGVPT~K VDKYYPTIVC VADNPYEGYA  
 
 
             ....|....| ....|....| ....|....| ....|....| ....|....|  
                     410        420        430        440        450         
A.a.         FFFADPVIPP ---------- -RERVITKMG KWAHYFK-TA FEKYFLW-KV  
A.f.         AFIALPQLKP ---------- -RKVDVFAYG RWVHLAK-VA FEKYFIR-KM  
R.c.         AFVAQPQIPP ---------- -RNVNWSSQG KWVHWAK-EG FERYFMH-KL  
A.h.         IFIAAPVVPD PSVG------ HRRHATALRG LWVNWAK-NA FEWYFLA-KM  
O.l.         VFVADPVLPD PKTG------ TRRRAITKRG KWVSWSK-TA FETFFLS-KM  
C.m.         TFVISDSKHG ---------- ---VVKYPPN RINHFLK-LT FAASYWS-ML  
V.d.         TFVISDFNNP ---------- ---AIKYPIN RVNHLFK-VA FAATYWD-MI  
A.am.        VSVKDDTWYG GTVSIADPAA VNHLKKELFT KYYMWTKGDM AL--~~~~~~  
 
 
             ....|....| ....|....| ....|....| ....|....| ....|....|  
                     460        470        480        490        500         
A.a.         RNGN--IAPS FEEKVLEIFL KVHPIELCKD CEGAPGSRC- ----------  
A.f.         KMGV-S-EPF YEKVL---FK MMGITRLKEE DTHRKAS--- ----------  
R.c.         RRGT-S-ETF YEKAA---MK LLGIDKLKAV KKG------- ----------  
A.h.         RWGT--AVPW FEKLG---LY LLRLTLVTPI SETPTQQKDL TSIKG-----  
O.l.         RFGL--AVPW FERWG---LR FMGLSLVEPL DTTRETGNQA FASKS-----  
C.m.         KYPE-LWDPL MEAYFEATSP ERLIGLFR-- ---------- ----------  
V.d.         LYPE-LWDPI FEAYFEATEP AKLRHLYR-- ---------- ----------  
A.am.        ---------- -EKFLASW-- ---------- ---------- ---------- 
                      * *  ** 
                                                   C-terminal 
 
Figure 3.1. Amino acid sequence alignment of several SQRs, including that from C. maquilingensis. 
The residues and regions of the sequences that are used to distinguish the 6 classes of SQRs are 
highlighted in gray.  The “1st and 2nd capping loops” and the extended C-terminal are also indicated.  
Asterisks mark the mutations made in the C. maquilingensis SQR.  A.a., Aquifex aeolicus Type I SQR; 
A.f., Acidithiobacillus ferrooxidans Type I SQR; R.c., Rhodobacter capsulatus Type I SQR; A.h. 
Anphotece halophytica Type I SQR; O.l., Oscillatoria limnetica Type I SQR; C.m., Caldivirga 
maquilingensis Type III SQR; V.d., Vulcanisaeta distributa Type III SQR; A.am., Acidianus ambivalens 




The primary goal of the current work was to obtain a protein designated as a type III SQR 
and verify that the protein, in fact, has the predicted enzymatic sulfide:quinone oxidoreductase 
activity. In order to address it, the Type III/SqrC SQR from Caldivirga maquilingensis [102], a 
hyperthermophilic crenarchaeon, was characterized.  This organism grows either anaerobically 
or microaerophilically optimally at 85o C under acidic conditions (pH 4).  The chromosomal 
gene encoding this enzyme was cloned and expressed in E. coli.  The enzyme is associated with 
the bacterial membrane and purified following detergent solubilization.  The C. maquilingensis 
SQR oxidizes sulfide, using decylubiquinone as the electron acceptor.  Since relatively little is 
known about the details of how monotopic membrane proteins bind to the membrane [100], a 
secondary goal was to define which portion(s) of the polypeptide are required for membrane 
binding. For that, site-directed mutagenesis was used to demonstrate that the C-terminal 
amphiphilic helix is both necessary and sufficient for membrane binding. 
 
3.2. MATERIALS AND METHODS 
Sequence analysis. 
Genes encoding SQRs were retrieved from the National Center for Biotechnology Information 
(NCBI) and Department of Energy Joint Genome Initiative (JGI) databases. The sequences were 
aligned using MUSCLE [103].  Conserved residues were identified with BIOEDIT (Hall TA, 
1999). Secondary structure was predicted by using PSIPRED v3.0 software [104]. 
 
Construction of expression plasmids and site-directed mutagenesis. 
The SQR from Caldivirga maquilingensis IC-167 [102] strain was cloned into pET22b (Apr, 




different point mutations. The His-tag (8 histidines) was introduced in the N-terminal and the 
final plasmids were transformed into E. coli C43 (DE3) strain (Avidis, France) containing 
pRARE (Cmr, Novagen). 
 
Cell growth, enzyme expression and purification. 
E. coli C43 cells were grown in LB medium with 100 µg/ml ampicillin and 20 µg/ml 
chloramphenicol at 37 ºC. Gene expression was induced by addition of 1 mM IPTG (isopropyl-
D-thiogalactoside) when cells reached an OD600 ~ 0.7. All purification procedures were carried 
out at 0-4º C. Cells were harvested and resuspended in buffer A (50 mM sodium phosphate, pH 
7.5, 300 mM NaCl) with 5 mM MgSO4, DNase I and a protease inhibitor cocktail (Sigma). The 
cells were then disrupted by passing twice through a microfluidizer at a pressure of 80,000 psi. 
The cell extract was centrifuged at 14,000 x g for 10 min to remove the unbroken cells. 
Membranes were obtained after centrifugation at 230,000 x g for 4 h. Pellets were resuspended 
in buffer A plus the protease inhibitor cocktail, and then solubilized by the addition of a stock 
solution of 20% DDM (dodecyl-β-D-maltoside) dropwise to a final concentration of 1%.  The 
suspension was incubated at 4º C for 2 h with mild agitation and then cleared by centrifugation at 
230,000 x g for 1 h. The supernatant was added to 5 ml Ni-NTA resin (Qiagen) pre-equilibrated 
with buffer A plus 0.05% DDM and 10 mM imidazole. The protein bound to the resin was 
washed with buffer A plus 0.05% DDM and 50 mM imidazole and then eluted with buffer A 
with 0.05% DDM and 200 mM imidazole. Fractions were concentrated by filtration, and the 
imidazole was removed by dialysis against buffer A plus 0.05% DDM.  The purified protein 






Protein concentration was determined using the BCA protein assay (Thermo Scientific, Pierce 
Protein Research Products). The protein purity was evaluated by SDS-PAGE using a 4-20 % 
gradient gel (NuSep). The FAD content of the pure protein was determined spectroscopically 
with an Agilent Technologies spectrophotometer (model 8453), using an extinction coefficient of 
10.8 cm-1 mM-1 for the oxidized flavin [105] after extraction from the protein by treatment of the 
sample with 5 % trichloroacetic acid [106]. No flavin was present in the precipitated protein 
pellet.  Additionally, fluorescence emission and excitation spectra of the supernatant and the 
resuspended pellet were recorded using a fluorescence spectrophotometer (Cary Eclipse, Agilent 
Technologies). The samples were excited at 365 nm and the emission spectra were recorded 
from 480 to 630 nm. The redox state of the flavin in the intact protein was monitored by the 
fluorescence excitation spectrum (emission wavelength of 520 nm), recorded at room 
temperature before and after the addition of different concentrations of sulfide (reductant) and 
quinone (oxidant). 
 
Enzyme activity assays.  
SQR activity was measured at 60º C. The 200 µL reaction mixture contained 50 mM sodium 
phosphate pH 7.5, 300 mM NaCl, 0.05% DDM, 10 µM to 200 µM decylubiquinone (Sigma), 
and 5 µg (0.55 µM) of the purified enzyme. The reaction was started with the addition of 25 µM 
to 250 µM sodium sulfide, prepared fresh with N2-flushed 50 mM sodium phosphate, pH 7.5.  
The reaction progress was monitored for 3 min by the decrease in absorption of decylubiquinone 




from Shahak et al [107]. An extinction coefficient of 12.4 cm-1 mM-1 at 275 nm was used to 
determine the extent of reduction of decylubiquinone [108]. 
 
Determination of kinetic constants.  
Kinetic parameters were determined using nonlinear least square analysis (Origin8.0) of the data 
fitted to the Michaelis–Menten rate equation (v = Vmax (S) ⁄ (Km + S), where v is the velocity, 
Vmax is the maximum velocity, S is the substrate concentration and Km is the Michaelis-Menten. 
The enzyme rates are expressed as a turnover number (kcat) based on the concentration of flavin, 
nmol quinone reduced s-1 nmol FAD-1. 
 
3.3. RESULTS 
Protein expression and characterization. 
Recently Marcia et al. [92] proposed a new classification of SQRs into six different groups.  
Analysis of the amino acid sequence of the SQR from C. maquilingensis (Fig. 3.1) reveals that 
this enzyme belongs to Type III, or SqrC according to the nomenclature of Gregersen et al. [84].  
The His-tagged protein was heterologously expressed in E. coli, solubilized from membranes 
using the detergent DDM, and purified by affinity chromatography. The protein yield was 2 mg 
from 1 liter of cell culture. SDS-PAGE analysis shows a single band with apparent molecular 
weight of 45 kDa (Fig. 3.2), similar to other SQRs [11, 92, 99, 109, 110].  The UV-visible 
spectrum shows the presence of FAD in the protein, and a shoulder at 465 nm indicating the 
cofactor is in an apolar environment [48] (Fig. 3.3A). Precipitation of the protein with 5% 
tricholoracetic acid leaves the FAD cofactor in solution, demonstrating that the FAD is not 




60% of the expected value based on one equivalent of FAD per SQR polypeptide. A low flavin 
content has been observed with other heterologously expressed flavoproteins and is not unusual 
[101, 111]. Several methods were attempted to increase the FAD content without success. 
Among the methods used were 1) addition of 0.5 mg/L riboflavin to the growth medium; 2) 
decrease the growth rate after induction with IPTG, by reducing both the temperature (to 30º C) 
and agitation rate (to 100 rpm); 3) reduction of the rate of protein expression by decreasing the 
IPTG concentration to 0.5 mM; 4) addition of 20 µM FAD to all of the purification buffers; and 
5) flavin reconstitution by a cycle of deflavination-flavination of the purified protein [112]. 
These were all unsuccessful at increasing the incorporation of FAD into the protein.   
 
 
Figure 3.2. Expression and purification of SQR, SQRT1 and SQRT2. SDS-PAGE gel showing the 
purified C. maquilingensis SQR (WT), along with the water-soluble truncated forms of the enzyme.  T1 
has the last 21 amino acids removed, including the C-terminal amphiphilic helix, and T2 lacks 45 amino 






Figure 3.3. UV-visible and fluorescence spectra of the purified C. maquilingensis SQR. (A) The pure 
protein exhibits a typical UV-visible absorption spectrum of a flavoprotein, with characteristic peaks at 
375 and 440 nm for the oxidized FAD. (B) After a brief incubation with 5% trichloroacetic acid at room 
temperature, the fluorescence emission spectra of supernatant (dashed line) and resuspended protein 
(straight line) were recorded between 470 nm and 650 nm (excitation at 365 nm).  The data show that the 
FAD is not covalently bound to the protein. 
 
The sulfide oxidase activity of the purified SQR was examined with several different 
quinones as oxidants: menadione, duroquinone, ubiquinone-1 and decylubiquinone. The highest 
steady state activity was observed with decylubiquinone (Table 3.1), and all subsequent 
characterizations were performed with decylubiquinone as the electron acceptor.  The steady 
state activity increased as a function of temperature between room temperature and 60°C, the 
highest temperature examined, to a value of 0.60 nmol quinone reduced s-1 nmol FAD-1 (kcat = 




above 60°C were not feasible. The activity was not increased by the addition of FAD (20 µM) to 
the assay buffer.  At 60°C, the Km values for both sulfide and decylubiquinone are in the 
micromolar range (Table 3.2).  The enzyme activity is inhibited completely in the presence of 
250 nM aurachin C, a quinone analogue [113, 114], and by iodoacetamide (300 µM), a 
sulfhydryl blocking agent, which is consistent with reports of SQRs from other organisms [81]. 
 
Table 3.1. Relative sulfide:quinone oxidoreductase activities of the  C. maquilingensis SQR 
with different short chain quinones. 
 





aActivity measured with decylubiquinone is 0.60 ± 0.07 nmol quinone reduced s-1 nmol FAD-1 (100%), 
and all activities are expressed as the percent relative to this value.  Measurements were performed at 

































aActivity is expressed as nanomol of decylubiquinone reduced per second per nanomol of FAD, measured 
as described in the text at 60 °C. Data are expressed as average ± SD of three independent experiments. 
 








WT membrane 0.60 ± 0.07 77 ± 8 30 ± 1 
SQRT1 cytoplasm 0 ---- ---- 





0.82 ± 0.04 46 ± 2 33 ± 3 
cytoplasm 
(50%) 
1.20 ± 0.08 77 ± 5 36 ± 2 
L379D/M380N membrane 
(50%) 
0 ---- ---- 
cytoplasm 
(50%) 
0 ---- ---- 
L379D membrane 0 ---- ---- 
L379N membrane 0 ---- ---- 
M380N membrane 0.62 ± 0.06 73 ± 6 32 ± 3 
Y383Q/F389K 
L379D/M380N 




Conversion of C. maquilingensis SQR from a membrane protein to a soluble protein 
The amino acid sequence analysis of C. maquilingensis SQR shows no predicted transmembrane 
helices.  Therefore, like other SQRs [96], the C. maquilingensis SQR is a monotopic membrane 
protein, using the classification of Blobel [115].  One experimental manifestation of this is that 
treating the E. coli membranes containing C. maquilingensis SQR with 1 M NaCl (or higher) 
results in quantitatively removing the protein from the membrane.  Although the salt-extracted 
enzyme has no sulfide:decylubiquione oxidoreductase activity, subsequent dialysis to remove the 
salt in the presence of 0.05% DDM fully restores the activity (not shown).  This indicates no 
irreversible damage has been done to the protein by this treatment.   
Monotypic membrane proteins have one or more segments that enter and leave the 
membrane bilayer from the same side.  A computational study [100] of 11 different monotopic 
membrane proteins showed that the interactions with the membrane were mediated primarily 
through hydrophobic amino acid residues (particularly F, L, I and V, but also Y and W) which 
insert into the non-polar portion of the bilayer, as well as basic residues (R and K, but also H to a 
lesser extent).  These residues may be distributed over the protein interface in contact with the 
membrane or may be localized within one or more amphiphilic helices.   
The C. maquilingensis SQR has two amphiphilic helices near the C-terminus (Fig. 3.4).  
The hypothesis that these mediate membrane binding was tested by site-directed mutagenesis 
both by removal of the helices and by point mutations (Table 3.2).  The mutated residues were 
chosen based on Heliquest software predictions [116]. The amino acids selected for mutation 
were hydrophobic and proposed to be located on the hydrophobic side of the helix (Fig. 3.4). 
Fig. 3.5 shows the X-ray structure of the C-terminal region of the SQR from A. ferrooxidans [98, 




One evident feature is that residues in the C-terminal amphipathic helices are also at or near the 
binding site for the substrate decylubiquinone (Fig. 3.5).  
 
 
Figure 3.4.  The amphiphilic helices at the C-terminal region of the C. maquilingensis SQR.  (A) 
Schematic showing the sequences and locations of the two amphipathic helices.  The sequence in red 
corresponds to the predicted amphiphilic helices, and the dashed lines indicate the locations of the C-
termini of the two truncations that result in water-soluble protein. (B) A helical wheel depiction of the 
amphiphilic helix closest to the C-terminus (Helix 2 in Panel A).  The sequence is shown, with the two 






Figure 3.5. A portion of the C-terminal structure of the Acidithiobacillus ferrooxidans SQR (PDB 
ID: 3T31) [98, 99] highlighting the homologous amino acids mutated in C. maquilingensis. F410 in 
the A. ferroxidans sequence corresponds to L379 residue in the C. maquilingensis sequence. DUQ: 
decylubiquinone. 
 
Truncations: Two constructs were made.  In SQRT1 a stop codon was introduced to eliminate 
the last 21 amino acids from the C-terminus, removing one putative amphiphilic helix.  Fig. 3.4B 
shows a helical wheel diagram of this helix. In construct SQRT2, the last 45 amino acids are 
removed, thus eliminating both of the amphiphilic helices (Fig. 3.4).  Both SQRT1 and SQRT2 
when expressed in E. coli resulted in water-soluble proteins (Table 3.2).  In each case the yield 
of protein was nearly 5-fold higher than the wild type construct, in which the recombinant 
protein is bound to the membrane.  The FAD content of each of the truncated proteins, as well as 
the characteristics of the absorption spectra, were identical to those of the detergent-solubilized, 
wild type SQR.  However, no sulfide:decylubiquinone oxidoreductase activity was observed in 











necessary and sufficient to mediate the binding of C. maquilingensis SQR to the membrane 
bilayer. 
Point mutations:  Several combinations of multiple mutations as well as single mutations in the 
C-terminal amphiphilic helix were examined. 
a) Y383Q/F384K/L379D/M380N: Guided by the amphiphilic pattern of the putative C-
terminal helix shown in Fig. 3.4, four point mutations were introduced into the SQR, replacing 
hydrophobic residues by polar or ionizable amino acids.  The resulting protein is found entirely 
in the cytoplasmic fraction but there is no catalytic activity (Table 3.2).  This shows that the 
complete deletion of the C-terminus is not required to free the protein from the membrane.   
b) Y383Q/F384K:  This double mutant corresponds to two of the four mutations shown 
above to eliminate membrane binding.   This protein was expressed in a yield similar to the wild 
type SQR, and was found equally in the cytoplasmic and membrane fractions after cell 
disruption (Table 3.2), i.e., half of the protein was found in a water-soluble form. The SQR was 
isolated from each fraction, using DDM to solubilize the membrane-bound fraction as with the 
wild type protein.  The isolated proteins from each fraction contained FAD to the same extent as 
the wild type SQR.  Remarkably, both the soluble and membrane-bound versions of this double-
mutant are catalytically active (sulfide:decylubiquinone oxidoreductase activity).  The 
comparison of the steady state kinetic parameters of the enzymes isolated from the membrane 
and cytoplasmic fractions is shown in Table 3.2.  The membrane-bound mutant enzyme has a 
specific activity about 30% higher than the wild type SQR and the Km for sulfide is about half of 
the value found for the wild type (46 µM vs. 77 µM).  The water-soluble version of this mutant 
SQR is twice as active as the wild type SQR (1.20 vs. 0.60 nmol quinone reduced s-1 nmol FAD-




membrane-bound form. This double mutant does not eliminate, but weakens the membrane 
association of the protein.  The soluble form is, however, functional with decylubiquinone as 
substrate. 
c) L379D/M380N:  This double mutant corresponds to the second pair of mutations in the 
quadruple mutant, Y383Q/F384K/L379D/M380N, which eliminates membrane binding. As with 
the Y383Q/F384K double mutant (above), the expressed protein was found in both the 
cytoplasmic and membrane fractions in equal proportions after disruption of the E. coli cells 
(Table 3.2), and each fraction had the same FAD content as the membrane-bound wild type SQR 
(about 50%).  The total yield of this recombinant protein was comparable to the wild type. 
However, both the membrane-bound and soluble forms of this protein were inactive (Table 3.2).  
Hence, this double mutant, like the Y383Q/F384K mutant described above, weakens the 
membrane affinity but does not eliminate membrane binding of the protein.  Furthermore, one or 
both of the mutations in the L379D/M380N double mutant must be responsible for the loss of 
catalytic activity. 
d) M380N: This is one of the two mutations in the L379D/M380N double mutant.  The 
M380N mutation by itself results in protein that is entirely membrane-bound, but which has the 
same activity as wild type SQR. Hence, this substitution by itself is not responsible for the loss 
of activity of the L379D/M380N double mutant but is insufficient to result in any of the 
recombinant protein being free of the membrane.   
e) L379D: This single mutation is responsible for the loss of catalytic activity of the 
Y383Q/F384K/L379D/M380N quadruple mutant of the C. maquilingensis SQR. All of the 
expressed protein is membrane-bound.  Because of the likely proximity of this region of the 




investigated further.  Fig. 3.6 shows the fluorescence excitation spectrum of the protein-bound 
flavin for the wild type as well as several mutant SQRs.  In each case the spectrum is shown: 1) 
in the absence of substrates; 2) after the addition of sulfide; and 3) after the subsequent addition 
of decylubiquinone.  For the wild type SQR as well as for each mutant examined, the addition of 
sulfide results in reduction of the bound FAD, and the lower intensity of the fluorescence. 
Subsequent addition of decylubiquinone to the wild type SQR restores the FAD to the oxidized 
state, with concomitant increase in the FAD fluorescence intensity.  The same result is obtained 
with the fully active M380N mutant.  However, the addition of decylubiquinone to the L379D 
mutant fails to reoxidize the protein-bound FAD (Table 2 and Fig. 3.6).  It is concluded that this 
mutant is inactive due to the selective perturbation of the interaction with decylubiquinone. 
f) L379N:  This mutation places a polar but non-ionizable residue in place of L379.  The 
mutant behaves identically to L379D, described above, and is inactive due to a perturbation of 
the decylubiquinone binding site (Fig. 3.6).  Hence, placing a potential negative charge at this 
site is not required to inactivate the enzyme. 
In summary, these data demonstrate that the affinity of recombinant C. maquilingensis 
SQR for the E. coli membrane is substantially reduced by the substitution of two amino acids in 
the C-terminal amphiphilic helix, resulting in half of the isolated protein being found in the 
cytoplasm.  Substitution of four non-polar residues in the amphiphilic helix with more polar 
amino acids is sufficient to convert the monotypic membrane protein to a water-soluble form.  
The role of the C-terminal amphiphilic helix in the binding of the quinone substrate is also 
demonstrated by the L379 mutations.  This is not surprising since in vivo the quinone must 





Figure 3.6. Fluorescence excitation spectra of purified wild type and mutant C. maquilingensis 
SQR. Excitation spectra are shown for (A) wild type, (B) M380N, (C) L379D and (D) L379N SQR 
proteins. Spectra were recorded prior to substrate addition, (black trace); 20 min after addition of 150 µM 
sulfide (red trace); 20 min after addition of 100 µM decylubiquinone (green trace). All experiments were 
performed at room temperature, resulting in slow oxidation and reduction of the FAD.  Reoxidation of the 
FAD upon addition of decylubiquinone is not observed for the L379D and L379N mutants. The protein 
concentration was 1 mg ml-1 (22 µM protein; ~11µM FAD). The emission was monitored at 520 nm.  
Data are representative of results of at least three separate experiments. AU: arbitrary units. 
 
3.4.  DISCUSSION 
Biochemical characteristics of the enzyme 
The first significant aspect of this work is the demonstration that the gene from C. 
maquilingensis predicted to encode a Type III/SqrC SQR [84, 117] does, indeed, encode an 




shown to be an SQR.  Furthermore, the C. maquilingensis SQR is only the second representative 
of SQR from an archaeal source, the first being from A. ambivalens [11, 118]. The activity of C. 
maquilingensis SQR is comparable to the activity reported for A. ambivalens SQR (at 50 °C) 
[11].  This is 10-fold slower than the SQR from R. capsulatus [110], 60-fold slower than the 
SQR from A. ferrooxidans [119] and 100-fold slower than the SQR from A. aeolicus (at 80 °C) 
[120]. 
 To date, all SQRs appear to contain FAD as a cofactor.  The SQRs from A. ambivalens 
[11] and from A. aeolicus [120] each have covalently-bound FAD linked to a cysteine residue. 
Although the homologous cysteine is present in the SQR from A. ferrooxidans [119], the FAD is 
non-covalently bound to this enzyme.  The homologous cysteine is not present in the sequence of 
C. maquilingensis SQR (Type III) or in Type II or bacterial Type V SQRs [92].  Also, it has been 
demonstrated in R. capsulatus SQR that mutation of this cysteine (C127S) does not alter the 
FAD content of the mutated enzyme compared to the wild type, although the sulfide-dependent 
reduction of the FAD is inhibited [101]. Certainly, when present, the cysteine at this sequence 
position in SQRs is at the FAD binding site, but this cysteine is not essential for all SQRs for 
either flavin binding or function. 
 
Attachment of the SQR protein to the membrane 
SQRs have no transmembrane segments and are classified as monotopic proteins [115].  Other 
monotopic proteins include prostaglandin H2 synthase-1 [121], prostaglandin H2 synthase-2 
[122], the electron transfer flavoprotein:ubiquinone oxidoreductase [123, 124], glycerol-3-
phosphate dehydrogenase [125] and oxidosqualene cyclase [126]. These proteins interact at the 




perturbation of the membrane may differ substantially for different monotopic proteins [100].  
There is no signature folding motif or sequence to identify the membrane-interacting domain(s).  
In some cases, the primary mode of attachment is through an amphiphilic helix which lies more-
or-less parallel to the plane of the bilayer with hydrophobic residues penetrating into the 
hydrophobic region of the membrane.  Examples are fatty acid amide hydrolase [127] and the 
electron transfer flavoprotein:ubiquinol oxidoreductase [123, 124]. Other monotopic membrane 
proteins interact through a hydrophobic patch consisting of residues from different parts of the 
protein sequence, exemplified by apocarotenoid cleavage oxygenase [[128].  Computational 
[100] as well as bioinformatics surveys [129] indicate that the stabilizing interactions are through 
hydrophobic residues and through basic residues which interact with the phospholipid 
headgroups.  It is noted that the membrane of C. maquilingensis, contains large amounts of 
tetraether core lipids [102], which are very different from the E. coli membrane lipids.  
Nevertheless, it is likely that the pattern of affinities of mutant SQRs for the E. coli membrane 
will also apply qualitatively for the natural membrane under physiological conditions.   
The C. maquilingensis SQR has two predicted amphiphilic helices near the C-terminus.  
The fact that the protein can be readily removed from the E. coli membrane by 1 M NaCl 
suggests that the membrane-protein interaction is fairly weak, consistent with the main 
interaction being through amphiphilic helices that do not penetrate deeply into the bilayer. The 
essential functional requirement is that the membrane-bound quinone must be able to access the 
FAD to facilitate electron transfer.  The X-ray structures of the SQRs from A. aeolicus [97] and 
from A. ferrooxidans [99] each contain a quinone, and each of these proteins has been modeled 
to interact with the membrane through two C-terminal amphiphilic helices, with an opening 




the quinone can access the reduced FADH2.  This is likely to also be true for the C. 
maquilingensis SQR.   
In attempting to define residues critical for membrane association by site-directed 
mutagenesis, the overlap between regions of the protein important for quinone interaction and for 
membrane binding is a complication.  This was encountered when the C-terminal helix was 
removed by truncation of the final 21 amino acid residues. The resulting protein is water-soluble 
but has no catalytic function, presumably because the access of the decylubiquinone substrate 
was perturbed in the mutant.  The same is also true for the L379D/M380N mutant SQR, half of 
which is isolated in a soluble form, but which has no catalytic activity.  The lack of activity was 
shown to be entirely due to mutation of L379, and the lack of enzyme activity is due to the 
inability of the protein-bound FADH2 to be oxidized by decylubiquinone (Table 2 and Fig. 3.6).  
L379 corresponds to F410 in the structure of A. ferrooxidans SQR (Fig. 3.6), which interacts 
with the aliphatic tail of decylubiquinone.  Hence, this mutation likely either restricts access of 
the quinone to the active site flavin, or destabilizes quinone binding.  
Mutation of the pair of residues Y383Q/F384K also results in 50% of the protein being 
water-soluble. However, in this case the soluble version of the C. maquilingensis SQR has twice 
the sulfide:decylubiquinone activity as the detergent-solubilized wild type enzyme. The 
decreased sulfide Km of the detergent-solubilized version of this mutant SQR could be related to 
the introduction of a positive charge close to the flavin, possibly altering the redox potential of 
the cofactor [130]. Alternatively, the positive charge of the lysine might increase the attraction of 
the anionic substrate (sulfide).  There are relatively few experimental data on the interactions of 
monotopic membrane proteins with the lipid bilayer [100].  The protein-membrane interaction of 




helix.  In order to convert 100% of the C. maquilingensis SQR to a water-soluble form, we 
substituted 4 hydrophobic amino acids within the C-terminal amphiphilic helix with polar 
residues. The data do not rule out favorable interactions between the membrane and the second 
putative amphiphilic helix located near the C-terminus (Fig. 3.4).  However, the data do show 
that membrane interactions with the C-terminal helix are necessary to maintain the C. 
maquilingensis SQR bound to the membrane, and are also important for the access of the 




4. STUDIES ON THE CALDIVIRGA MAQUILINGENSIS TYPE III SULFIDE 
QUINONE OXIDOREDUCTASE: THE OLIGOMERIC STATE IS INDEPENDENT 
FROM MEMBRANE BINDING 
 
4.1. INTRODUCTION 
 Sulfide:quinone oxidoreductase (SQRs) belong to the two dinucleotide binding domains 
flavoproteins (tDBDF) super-family, characterized by the presence of two Rossmann fold 
domains known to stabilize the adenosine moieties of dinucleotides (e.g. FAD and NADH) [13]. 
SQRs are typically oligomeric flavoproteins with multiple copies of a single subunit of 
molecular mass of about 50 kDa. SQRs are associated with the prokaryotic cytoplasmic or 
periplasmic membrane or the inner mitochondrial membrane. They have been characterized so 
far from each domain of life: Bacteria [110, 118, 131-134], Archaea [10, 11] and Eukarya [111, 
135, 136]. Dimeric and trimeric forms of SQRs have been observed in X-ray structures, 
postulating the C-terminal amphipatic helices as the domain responsible for oligomerization [11, 
92, 96, 97], similar to other monotopic tDBDF such as type 2 NADH dehydrogenases (NDH-2s) 
[23-25]. In the current work we examine whether the C-terminal amphipathic helices are critical 
for oligomerization of the SQR from Caldivirga maquilingensis. 
 SQRs are classified into six types based on sequence and structural alignments [117], and 
amino acid residues for the FAD cofactor and substrates binding sites are predicted for each 
group, as part of the classification criteria. In types I and V, for which crystal structures are 
available, a conserved cysteine is involved in FAD binding [11, 99, 120]. Type III SQRs, like C. 




tryptophan instead, and are structurally more related to Flavocytochrome c Sulfide 
Dehydrogenase (FCSD) than to other SQRs [117].  
 Previous studies demonstrated that the C-terminal domain of C. maquilingensis SQR 
(CmSQR) is important for membrane binding [10]. Replacing four hydrophobic amino acids in 
the last amphipathic helix are enough to strip the protein from the membrane. This soluble 
quadruple-mutant is inactive due to the change in a single leucine residue, CmLeu379 that affects 
quinone reduction. Recently, several amino acids around the quinone polar head have been 
shown to be important for binding and catalysis in the homologous Acidithiobacillus 
ferrooxidans SQR (AfSQR) [137], for which there is an X-ray structure available [99].  No 
structure is available for CmSQR, but based on sequence alignments, CmLeu379 corresponds 
with AfPhe410, which is at the quinone binding site.  
 In the present work, site-directed mutagenesis was used to determine the importance of 
other residues to the oligomeric state, as well as to the FAD and quinone binding sites, for 
CmSQR.  
 
4.2. MATERIALS AND METHODS 
Sequence-structure analysis 
Gene sequences encoding SQRs and FCSD were retrieved from the National Center for 
Biotechnology Information (NCBI) database. The sequences were aligned using MUSCLE [103] 
and conserved residues were identified with Jalview [138].  To predict the 3D homology model 
of C. maquilingensis SQR, the online server for protein fold recognition Phyre2 (Protein 




structure was analyzed using VMD [140] and the software Ligplot+ [141] was used for helping 
visualization and representation of interactions between ligands and surrounding residues. 
 
Construction of expression plasmids and site-directed mutagenesis 
The SQR from C. maquilingensis IC-167 strain [102] was previously cloned into pET22b (Apr, 
Novagen) [10].  A Quik Change site-directed mutagenesis kit (Stratagene) was used to construct 
the different point mutations, and the final plasmids were transformed into E. coli c43 (DE3) 
strain (Avidis, France) containing the pRARE plasmid (Cmr, Novagen). 
 
Cell growth, enzyme expression and purification 
Cell growth and protein purification were performed as previously described [10]. E. coli c43 
cells containing the expression plasmids were grown in LB medium with 100 µg/ml ampicillin 
and 20 µg/ml chloramphenicol at 37 °C, and expression was induced by addition of 1 mM IPTG 
(isopropyl-D-thiogalactoside) when cells reached an OD600 ~ 0.7. Purification was carried out at 
0–4 °C. Cells were harvested and resuspended in buffer A (50 mM sodium phosphate, pH 7.5, 
300 mM NaCl) with 5 mM MgSO4, DNase I and a protease inhibitor cocktail (Sigma). Then, 
cells were disrupted by passing three times through a microfluidizer at a pressure of 80,000 psi. 
The cell extract was centrifuged at 14,000 ×g for 10 min to remove unbroken cells. The 
supernatants were collected and directly added to 5 ml Ni-NTA resin (Qiagen) pre-equilibrated 
with buffer A plus 10 mM imidazole. The protein bound to the resin was washed with buffer A 
plus 50 mM imidazole and then eluted with buffer A with and 200 mM imidazole. Fractions 
were concentrated by filtration, and the imidazole was removed by dialysis against buffer A. 




4 h. Pellets were resuspended in buffer A plus the protease inhibitor cocktail, and then 
solubilized by the addition of a stock solution of 20% DDM (dodecyl-β-D-maltoside) dropwise 
to a final concentration of 1%. The suspension was incubated at 4 °C for 2 h with mild agitation 
and then cleared by centrifugation at 230,000 ×g for 1 h. The supernatant was added to 5 ml Ni-
NTA resin (Qiagen) and membrane bound proteins were purified following a similar protocol, 
with 0.05% DDM added to all buffers. The purified protein samples were stored frozen at -80 °C 
after the addition of glycerol to a final concentration of 10%. 
 
Native PAGE 
Non-denaturing electrophoresis was performed in 4-20% precast Tris-Glycine gels (Nusep) in 
the presence of Tris-Glycine native running buffer supplemented with 0.01% DDM. For Blue-
Native PAGE, 0.02% of Coomassie Brilliant Blue G was added to the cathode buffer until 
samples ran for 1 cm into the gel, following this the coomassie-stained buffer was removed and 
replaced with clear Tris-Glycine native running buffer.  The chamber was placed in a mix of ice-
water at 4°C, to avoid heating of the samples, and gels were run for 4 h at 150 mV [142, 143]. 
 
Crosslinking assays 
20 µM of purified protein were incubated at room temperature for 5 minutes with 1.25 mM of 
glutaraldehyde (Sigma) in 10 mM HEPES buffer, pH 8.2, containing 0.05% DDM. The reaction 
was quenched with 100 mM Tris-HCl buffer, pH 7.4, and the crosslinked protein samples were 
analyzed by SDS-PAGE. Crosslinking experiments with 3,3'-dithiobis(sulfosuccinimidyl 
propionate) (DTSSP), were carried out according to manufacturer’s directions at room 




was added to the protein in buffer A. Alternatively, 4 µM of protein were incubated with 1 ml of 
10 mg/ml 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) membrane vesicles (see 
preparation below), in the presence or absence of β-mercaptoethanol and/or the crosslinker. 
 
Membrane vesicles preparation 
Membrane vesicles were prepared by resuspending a dried film of POPC in 50 mM sodium 
phosphate pH 7.5, to a final concentration of 10 mg/ml POPC in buffer A. Resuspension was 
followed by sonication and a series of freeze-thaw cycles, as established by Ingólfsson et al. 
[144]. No extrusion steps were performed since no specific vesicle size was required. 
 
Western blot analysis 
After SDS-PAGE, protein bands were transferred to a PVDF membrane and the WesternBreeze 
Chromogenic Western Blot Immunodetection Kit (Life Technologies) was used for detection of 
purified tagged proteins.  His-tagged proteins were detected using a monoclonal anti-
polyhistidine−alkaline phosphatase antibody produced in mouse (Sigma). FLAG-tagged proteins 
were detected by chemoluminescence using a monoclonal ANTI-FLAG® M2-peroxidase (HRP) 
antibody produced in mouse (Sigma), followed by development with a mix of 1.25 mM luminol, 
22.5 pM coumaric acid and 2.6 mM of H2O2 [145].   
 
Gel-filtration chromatography 
Gel-filtration analysis was carried out using a Superdex 200 10/300 GL column (GE Healthcare) 




was calibrated using BioRad molecular standards and elution was monitored by following 
absorption at 280 nm and 450 nm (FAD peak) on an ÄKTA FPLC system (GE healthcare). 
 
Enzyme activity assays 
SQR activity was measured at 60º C. The 200 µL reaction mixture contained buffer A with 
0.05% DDM, 100 µM decylubiquinone (Sigma), and 5 µg (0.55 µM) of the purified enzyme. The 
reaction was started with the addition of 250 µM sodium sulfide, prepared freshly with N2-
flushed buffer A.  The reaction progress was monitored for 3 min by the decrease in absorption 
of decylubiquinone at 275 nm [146]. An extinction coefficient of 12.4 cm-1 mM-1 was used to 
determine the extent of reduction of the quinone [108]. 
 
Determination of kinetic constants  
Kinetic parameters were determined using nonlinear least square analysis (Origin8.0) of the data 
fitted to the Michaelis–Menten rate equation (v = Vmax (S) ⁄ (Km + S), where v is the velocity, 
Vmax is the maximum velocity, S is the substrate concentration and Km is the Michaelis-Menten. 
The enzyme rates are expressed as a turnover number (kcat) based on µmol quinone reduced s-1 
µmol FAD-1. 
 
Other analytical methods 
Protein concentration was determined using the BCA protein assay (Thermo Scientific, Pierce 
Protein Research Products). The flavin content of the isolated SQR protein was determined in a 
dual-wavelength spectrophotometer (Agilent Technologies spectrophotometer 8453), using an 




protein by treatment of the sample with 5 % trichloroacetic acid [106].  The redox state of the 
flavin in the intact protein was also monitored by the fluorescence excitation spectrum using a 
fluorescence spectrophotometer (Cary Eclipse, Agilent Technologies) (emission wavelength of 
520 nm), which was recorded aerobically at room temperature before and after the addition of 
different concentrations of sulfide (reductant) and quinone (oxidant). It is worth noticing that C. 
maquilingensis SQR oxidation by oxygen is undetectable at room temperature. 
 
4.3. RESULTS 
C. maquilingensis SQR homology model resembles FCSD, NDH-2 and other SQRs 
CmSQR homology model was constructed using the web-based bioinformatics server Phyre2. 
This allows the prediction of protein structure, based on identification of homologous sequences, 
generation of a multiple-sequence alignment and secondary structure predictions, which are then 
combined into a query hidden Markov model (HMM) that is scanned against a fold library of 
HMMs of known structure. The highest scoring alignments are used to generate three-
dimensional backbone models, and the final three-dimensional structural model is generated after 
modeling of loops and fitting of side-chains. 
 97% of C. maquilingensis SQR was modelled at >90% confidence. Six templates were 
finally selected to model the protein based on heuristics to maximize confidence, percentage 
identity and alignment coverage. These were the flavin binding subunit of FCSDs from 
Thioalkalivibrio paradoxus and A. vinosum, the SQRs from A. ferrooxidans and A. aeolicus, and 





The type III CmSQR is a dimer and its oligomeric state is independent of the membrane 
binding 
In order to determine the oligomeric state of C. maquilingensis SQR, and the importance of the 
C-terminal region for oligomerization, a previously developed set of mutants was used [10]. 
These are soluble variants, unable to bind to the membrane, lacking either four hydrophobic 
residues from the last C-terminal helix (quadruple-mutant or YL), the complete last C-terminal 
helix (truncated 1 or T1) or the last two C-terminal helices (truncated 2 or T2) (Fig. 4.1A). 
 
 
Figure 4.1. Oligomeric state of WT and soluble mutants by Blue Native-PAGE. (A) Soluble mutants 
were previously constructed by truncation of one (T1) or both (T2) C-terminal helices, and by point 
mutations of the four amino acids underlined in the last helix (YL) [10]. (B) 5 (left) and 10 µg (right) of 
each protein sample were loaded in native buffer plus Coomassie Brilliant Blue G. Arrows indicate bands 
corresponding to the monomer (1x), dimer (2x) and trimer (3x) complexes (about 46, 88 and 139 kDa, 
respectively). The bands of the protein ladder (center lane) represent: Apoferritin band 1 (720 kDa), 
Apoferritin band 2 (480 kDa), β-phycoerythrin (242 kDa), lactate dehydrogenase (146 kDa), bovine 





 Initially, the oligomeric state of the WT and soluble mutants were evaluated in blue 
native polyacrylamide gels (BN-PAGE). This approach negatively charges all proteins allowing 
separation by mass only.  Here, the wild-type (WT) and Truncated 2 (T2) proteins, showed bands 
corresponding to monomer, dimer and trimer states. The Truncated 1 (T1) and quadruple mutant 
(YL) showed only a monomer-dimer equilibrium (Fig. 4.1 A and B).   
 Next, WT and soluble mutants were run through size exclusion chromatography (SEC), 
where only retention times corresponding to dimer forms (83-89 kDa) were observed. 
 Since BN-PAGE results indicate the presence of an extra trimeric form for the WT and 
T2 proteins, not observed with SEC, additional crosslinking experiments were performed. 
 Chemical crosslinkers can covalently join two or more molecules, keeping oligomers 
together as they run in a denaturing gel. In this study, two different compounds were used for 
this purpose, the promiscuous glutaraldehyde and the more specific, DTSSP.  
 Incubation with glutaraldehyde resulted in WT, YL and T2 variants displaying bands 
corresponding to a monomer-dimer-trimer equilibrium (Fig. 4.2A).  T1 however, was highly 
unstable in solution and aggregated in presence of the crosslinker. Since glutaraldehyde is highly 
length-unspecific, crosslinking with DTSSP was also used to evaluate oligomer formation. 
DTSSP allows covalent binding specifically between primary amines located up to 12 Å apart. 






Figure 4.2. Oligomeric state of WT and soluble mutants by crosslinking assay. (A) 4 µM (0.2 mg/ml) 
of WT and mutated protein was run in an SDS-PAGE after a 5 min incubation in the absence (-) or 
presence (+) of 1.25 mM glutaraldehyde. (B) 4 µM (0.2 mg/ml) of WT protein were incubated in the 
absence (C: control) or presence of different crosslinkers (Glu: glutaraldehyde; DT: DTSSP) and β-
mercaptoethanol (DTβ: DTSSP+ β-mercaptoethanol), without or with lipid vesicles as indicated. Controls 
were run without and with β- mercaptoethanol (βm).  
 
 It is possible that SQR monomers associate through hydrophobic regions only to avoid 
contact with the polar solvent, as proposed for A. ferrooxidans SQR [99]. Thus, crosslinking was 
also performed in the presence of liposomes, to mimic the membrane hydrophobic environment 
(Fig. 4.2B). Similarly to what is seen in solution, an intense band corresponding to the dimer 
state was observed for C. maquilingensis SQR, after crosslinking in the presence of lipid 
membranes (Fig. 4.2B).  
 Taken together, BN-PAGE, SEC and crosslinking results suggest that the type III SQR is 
in a dimeric state and this is not affected by the absence of the C-terminal domain.  
 
SQR dimerization is necessary for membrane binding  
It is proposed that variations between the C-terminal domain of monotopic proteins, result in 




SQR, it has been suggested that membrane insertion stabilizes oligomerization of the trimer and 
vice versa [97]. The yeast type 2 NADH dehydrogenase or NDH-2, a closely related tDBD 
flavoprotein, forms a larger hydrophobic patch when it dimerizes, facilitating membrane binding 
[24], while the bacterial version shows two separate membrane binding regions that do not 
converge in the dimer [25]. As described in the previous section, membrane binding was not 
essential for dimer formation in CmSQR however, it remained unknown if formation of the 
dimer was advantageous for binding to the membrane. Specifically, we attempted to elucidate if 
the presence of the membrane binding regions from both monomers is necessary for binding. 
 To investigate this, formation of heterooligomers of differentially tagged CmSQR 
variants was examined. One gene copy encoding a His-tagged WT protein was co-expressed 
with a second gene copy encoding a FLAG-tagged WT or soluble mutant variant, unable to bind 
to the membrane (Fig. 4.3A). Following expression and protein synthesis, all samples were run 
through a Ni-NTA column, isolating any oligomer containing the His-tagged WT protein. After 
purification, the protein variants were run through an SDS-PAGE and two simultaneous western 
blots were performed, where one membrane was developed using anti-His antibodies, and anti-








Figure 4.3.  Oligomeric state of WT and soluble mutants by double-tag protein approach.  (A) 
Constructs containing His-tagged (blue) and Flag-tagged (red) SQR homo- and heterodimers. (B) Ni-
NTA purified samples were run in SDS-PAGE, transferred to PVDF membranes and developed by anti-
His-tag and anti-Flag-tag antibodies. WT, YL and T2 lanes correspond to His-tagged homodimers 
(synthesized using single-copy constructs). WT-WT, YL-WT and T2-WT lanes correspond to His-tagged 
and FLAG-tagged homo- and heterodimers, purified from membrane (m) or cytosolic (c) fractions.  
 
 WT-WT, YL-WT and T2-WT showed a band corresponding to the FLAG-tagged WT 
SQR (Fig. 4.3B), indicating formation of heterodimers with FLAG-tagged WT and His-tagged 
WT, YL or T2. No protein production was detected for the T1-WT construct, in agreement with 
the previous instability observed for T1 during crosslinking experiments. T2-WT shows an extra 
band corresponding to the size of the dimer. T2 lacks a large segment from the C-terminal 
domain, which could partially expose the hydrophobic interior of the monomer, leading to 
additional interactions that help stabilizing the dimer.  
 The WT-WT homodimer was the only complex found in the membrane, while the WT-
YL and WT-T2 heterooligomers could only be isolated from the cytoplasmic fraction (Fig. 
4.3B). This suggests the need of both monomers membrane binding regions, for attachment. 
 
CmSQR shows conserved residues for FAD and quinone binding 
In lack of a crystal structure for a type III SQR, mutational studies were performed based on 




FAD binding site characterization. Type III SQRs lack the characteristic Cys residue seen for 
FAD binding, in the better-known type I and type V proteins, and a Tyr or Trp residue has been 
described to be conserved instead [117]. However, in the homologous model, CmTyr126 is seen 
at a distant location from the flavin cofactor. 
 To further investigate the FAD binding site, amino acids interacting with the cofactor in 
the aligned structures were first observed using the Ligplot+ software, which allows a simplified 
view of all different interactions between a protein and its cofactors [141]. Conserved residues 
between A. vinosum FCSD and C. maquilingensis, A. ferrooxidans, A. aeolicus and A. 
ambivalens SQRs, were identified and mutated in CmSQR. 
 In all five analyzed structures, Gly12, Gly16, Ala77 and Gly299 (C. maquilingensis 
numbering) can be seen at hydrogen bond distance to the adenine ring, pyrophosphate moiety 






Figure 4.4. Residues involved in the putative FAD binding site.  Three amino acids among SQRs and 
FCSD are conserved and interacting with FAD through hydrogen bonds. (A) Overlapped residues and 
cofactors from PDB structures from A. vinosum FCSD (yellow), A. ferrooxidans (blue) are compared to 
those from the C. maquilingensis SQR model (red). DUQ: decylubiquinone. (B) WT and mutants were 
assayed for activity in the absence and presence of additional FAD as indicated. The FAD content of each 
protein was quantified after extraction by TCA treatment.  100% activity corresponds to 0.76 ± 0.03 µM 
of reduced DUQ per µM protein-1 per sec-1. (C) FAD UV-Visible spectrum of the G299I mutant 
compared to WT. (D) WT and (E) G299I fluorescence excitation spectra before (black) and after addition 





 CmGly12 and CmGly16 can be seen at a short distance of the phosphate groups 
connecting the adenosine and the isoalloxazine ring. These were initially mutated to Ala, adding 
the smallest side chain possible. Gly12Ala only showed a slight drop in activity and FAD 
content, however addition of external flavin did not have any rescue effect. Gly16Ala resulted in 
a loss of FAD content to less than half of the WT and a 20-fold drop in activity that could not be 
recovered by addition of external flavin (Fig. 4.4B). This residue was also substituted for Ile but 
resulted in a severe reduction in yield, suggesting an even stronger effect in protein stability and 
folding in the presence of a larger side chain.   
 CmAla77, which is in close contact with the adenine portion of FAD, was mutated to 
Gly, removing the -CH3 side chain. Ala77Gly resulted in the loss of over half the flavin content 
and a 4-fold reduction in activity compared to the WT protein. FAD content and activity 
however, were almost fully restored after addition of external flavin (Fig. 4.4B), in accordance 
with a role in flavin binding.  
 Lastly, CmGly299 is at less than 3	Å from the isoalloxazine ring (Fig. 4.4A). Replacing 
this residue for Ile resulted in a complete loss of activity although FAD content remained 
unchanged. Additionally, the flavin spectrum for this mutant is red shifted and shows a change in 
height of the beta and gamma FAD peaks (Fig. 4.4C), indicating a perturbation in the cofactor 
environment [48]. The equivalent Gly residue in A. ferrooxidans (AfGly322) has been described 
to affect FAD and quinone reduction [137]. Thus, in order to further investigate the effect of this 
mutation, the catalyzed half reactions (reduction of FAD by sulfide and reoxidation by quinone) 
were analyzed separately. The FAD cofactor in this mutant was able to get reduced by sulfide, 
but no reoxidation was observed after quinone addition (Fig. 4.4 D and E), indicating the 




 An additional Pro, absent in FCSD, was also mutated based on previous mutational 
studies on S. cerevisiae NdiI and A. ferrooxidans SQR, associating this residue to FAD and 
quinone binding, respectively (Fig. 4.4A) [137, 147]. This residue can be seen at 3-5	Å from the 
isoalloxazine ring of the flavin and the quinone ring in A. ferrooxidans and S. cerevisiae NdiI. 
Mutation to Ala (CmPro44Ala) led to loss of almost 2-fold the flavin amount compared to WT 
and ¾ reduction in activity that could be greatly restored after addition of external FAD. 
CmPro44 was additionally changed to Phe but this protein version could not be detected after 
overexpression, suggesting an unstable conformation. 
 In sum, three residues could be associated to FAD binding, CmGly16, CmAla77 and 
CmPro44, based on the flavin loss observed upon mutation of these. Interestingly, a rescue effect 
was seen after addition of external flavin for the CmAla77Gly and CmPro44Ala mutants, but not 
for CmGly16Ala, suggesting a bigger conformational change caused by this mutation.  The 
change observed upon mutation of CmGy299 suggests a different type of role for this position, 
more related to catalysis.   
Quinone binding site characterization: There are no quinone binding motifs described for 
these monotopic proteins however two available X-ray structures for type I SQRs, have been 
crystallized in the presence of quinone: the A. aeolicus and A. ferrooxidans (PDB access codes 
3HYW and 3T31) [97, 99]. These were considered to study C. maquilingensis SQR quinone 
binding residues. 
 As it can be seen in these quinone-bound crystal structures [97, 99, 137], the quinone ring 
is located between two hydrophobic residues: AfPhe357 and AfPhe394 for A. ferrooxidans SQR, 
and AqIle348 and AqPhe385 for the A. aeolicus enzyme. The residue corresponding to 




sequence or structural alignments, respectively. Mutating CmPro327 to Ala, resulted in a slight 
increase in Km for the quinone but a surprising improvement in enzyme activity (Fig. 4.5). On 
the other hand, when CmPhe337 was mutated to Ala, activity was undetectable. 
 
 
Figure 4.5.  Residues involved in the putative quinone binding site. C. maquilingensis SQR structural 
model (red) overlapped with (A) A. ferrooxidans SQR (Af, blue) and (B) A. aeolicus (Aq, green) SQR 
crystal structures, shows conserved residues surrounding the quinone substrate. (C) Activity and Km for 
decylubiquinone of WT and mutants. 100% activity corresponds to 0.76 ± 0.03 µM of reduced DUQ. µM 
protein-1.sec-1; n.d.: not detected; N.D.: not determined 
 
 CmPhe362 corresponds to AqPhe385 and AfPhe394, whose aromatic rings can be seen 
stacked with the quinone ring. When CmPhe362 was replaced by Ala, Tyr or Trp, activity 
dropped by up to 85% compared to WT and the Km for quinone increased in relation with a 
bigger amino acid placed at this position. 
 In addition to these hydrophobic amino acids, a third conserved residue can be seen in the 
quinone surroundings, corresponding to AqLys382 and AfLys391: CmLys359. This amino acid 
has been postulated to hydrogen bond to the quinone through its backbone amide, and to the 




[137]. Replacement of CmLys359 by Ala, only caused about 50% loss of activity, and a 3-fold 
increase in Km for the quinone. 
 Essentially, C. maquilingensis SQR model displays conserved residues around the 
quinone ring, in agreement with what has been observed for A. ferrooxidans and A. aeolicus 
SQR structures [99, 120]. This involves the presence of two hydrophobic residues sandwiching 
the quinone ring (CmPhe362 and CmPhe337) and a conserved Lys (CmLys359) in the vicinity.  
  
4.4. DISCUSSION 
Oligomeric state and membrane attachment in Type III SQR 
The first important finding of this work is the experimental determination of C. maquilingensis 
type III SQR dimeric nature and the fact that it is unrelated to its membrane attachment domain. 
These are the first mutational studies regarding oligomerization, after dimeric and trimeric 
versions had been observed for type I and type V SQRs upon structure determination. 
SQRs have been described as dimers or trimers, as well as existing in a monomer-dimer 
[99] or monomer-dimer-trimer equilibrium [97].  Dimeric and trimeric X-ray structures are 
available for type I SQRs [97, 99, 119]. A dimer has also been described for a type V SQR from 
A. ambivalens, but the fact that the crystallized form lacks a large portion of its C-terminal, 
exposing the hydrophobic interior, led us not to consider it for our analysis [11].  The C-terminal 
domain is observed at the oligomer interface in A. aeolicus and A. ferrooxidans SQR structures 
[97, 99]. In the case of the A. aeolicus enzyme, it has been proposed that membrane insertion 
stabilizes oligomerization and, vice versa, with the trimer creating an adequate surface for 
membrane binding. Moreover, the coupling between membrane insertion, trimerization, and 




other soluble cytoplasmic electron acceptors [97].  A. ferrooxidans SQR however, has been 
suggested to be a monomer in its membrane-bound form, attaching through the same region 
needed for oligomerization [99].  
Here, the type III SQR from C. maquilingensis has been used as a model, for studying the 
significance of this protein membrane attachment in its oligomeric state, and systematically 
demonstrated that it is dimeric even in its truncated and other soluble forms (Fig. 4.1-4.3). The 
dimer does not get disrupted in order to bind to the membrane, as it can be observed by 
crosslinking after incubation with lipid vesicles (Fig. 4.2).  
Interestingly, a T2-WT hetero-oligomer shows a stronger dimerization interaction (Fig. 
4.3B), possibly due to exposure of hydrophobic inside residues, similar to what is seen in A. 
ambivalens truncated SQR structure [11]. 
SQRs are members of the tDBDF super-family, characterized by the presence of two 
dinucleotide binding domains known to stabilize the adenosine moieties of dinucleotides, such as 
FAD and NADH/NAD+ [13]. Thus, SQR structures can be compared to other related monotopic 
flavoproteins from this family, such as type 2 NADH dehydrogenases (NDH-2s) [23-25]. The 
crystal structure and experimental data on S. cerevisiae NDH-2 (Ndi1) showed that the enzyme 
dimerization of two monomers assists to condense the C-terminal domains into one large 
membrane-anchoring structure, where two last a-helices are important for dimerization and 
membrane binding [23, 24]. In contrast, the bacterial NDH-2 dimer has two spatially separated 
membrane-anchoring regions, which are not required for the dimerization to occur [25]. In C. 
maquilingensis SQR dimerization is not affected by mutations that disturb binding to the 
membrane, but the presence of membrane binding regions from both monomers is necessary for 




membrane binding, similar to the bacterial NDH-2, but it seems likely that the membrane 
binding regions from both monomers combine into a larger hydrophobic area, as seen in Ndi1. 
 
FAD binding site in C. maquilingensis type III SQR 
The FAD cofactor needs to be located in a specific environment inside the enzyme structure and 
plays a central role in the redox catalytic mechanism. The surrounding residues are responsible 
for stabilizing the flavin in the right position, allowing it to participate in the passage of electrons 
between the enzyme substrates (sulfide and quinone in case of SQRs). This also keeps the 
cofactor protected from the environment avoiding its unspecific reactions with other redox 
compounds in the cell, and production of reactive oxygen species [148, 149]. Different parts of 
the flavin; isoalloxazine ring, ribityl phosphate and adenosine monophosphate moiety have been 
proposed to interact with diverse motifs or amino acids in other flavoproteins [150].  
 In C. maquilingensis SQR, the predicted FAD-binding residue for type III SQRs can be 
seen at a significant distance from the cofactor in the constructed model (CmTyr123). However, 
four amino acids surrounding the FAD putative binding site, showed to be conserved between 
FCSD and SQRs: CmGly12, CmGly16, CmAla77 and CmGly299. CmGly12 and CmSQR16 are 
part of the Rossman fold motif [151, 152] and have been described to interact with the flavin 
phosphate groups. However, only CmGly16, which has been seen to stabilize the negative charge 
as part of the positive N-terminus of the a-1 helix [99, 152], showed a strong effect in FAD 
content when mutated. CmAla77 can be seen interacting with the adenosine ring, also suggesting 
a role in stabilizing the flavin. It showed to be important for keeping the cofactor bound to the 
enzyme and full recovery of activity upon addition of external flavin (Fig. 4.4 A and B). 




the flavin but proved to be defective only for quinone reduction. Surprisingly, the equivalent 
residue in A. ferrooxidans (AfGly322) has been described to also affect FAD reduction [137], 
suggesting further differences between type I and type III SQRs active sites. CmPro44, absent in 
FCSD but conserved in SQRs and NDH-2s, also influencde FAD content, reflecting additional 
similarities between these two families. 
 
Quinone binding site in C. maquilingensis Type III SQR 
Quinones localize in the lipid bilayer due to their lipophilic nature, allowing exchange with the 
quinone pool present in the membrane. There is no well-defined structural binding motif to 
predict quinone binding, but some general features can be highlighted. Quinone-binding sites are 
hydrophobic and can have several aromatic residues within 4 Å of the quinone molecule [153].  
In type I SQR structures, the aromatic ring of the quinone fits between two bulky 
hydrophobic residues (Fig. 4.5 A and B). The aliphatic side chain of the quinone extends towards 
the membrane attachment domain, and it interacts with the hydrophobic side chains of several 
amino acids [97, 99, 137]. Additionally, a network of solvent molecules and conserved charged 
amino acids can surround the benzoquinone ring [97]. 
 Similar to A. aeolicus and A. ferrooxidans, in C. maquilingensis SQR two hydrophobic 
residues (Phe337 and Phe362) and a Lys (359) residue appear in close vicinity with the quinone 
ring and show different effects in Km and kcat when mutated, compared to the WT protein (Fig. 
4.5). Among these, CmPhe337 seems to be absolutely essential for catalysis, as its absence yields 
a completely inactive enzyme. Mutations in CmPhe362 affected activity only partially. This 
differs to what has been observed for A. ferrooxidans, where both Phe residues sandwiching the 




As seen for A. ferrooxidans SQR, mutations in CmPhe362 and CmLys359 affected 
mainly the Km for quinone, consistently with a role in delimiting the pocket for the quinone 
molecule and restricting its dimensions for the right substrate [137] (Fig 4.5). Surprisingly, 
CmLys359Ala remains highly active, unlike mutations to the equivalent AfLys391, which 
completely inactivate the enzyme possibly due to its proposed strong interactions with FAD 
[137]. 
CmLeu379 has been previously shown to be crucial for C. maquilingensis SQR activity 
and postulated to interact with the quinone ring in a stacking fashion [10]. In the recently studied 
model, this residue cannot be seen in close distance with the quinone ring suggesting it could be 
located close to the hydrophobic tail. No further amino acids were mutated towards the C-
terminal domain, as this region is not conserved, and the quinone tails from A. aeolicus and A. 
ferrooxidans do not superimpose when protein structures are overlapped (Fig 4.5).  
Summarizing, three residues, spatially conserved in other quinone-bound SQR structures, 
were found to interact with the quinone molecule in C. maquilingensis SQR. CmPhe337 and 
CmPhe362 likely stabilize the quinone ring by stacking, and CmPhe337 is essential for enzyme 
activity. Moreover, CmPhe362 together with CmLys359 seem to have a more structurally related 








Inside the cell, oxygen can be partially reduced by quinones, metal centers and flavin cofactors, 
leading to endogenous formation of reactive oxygen species (ROS), like superoxide (O2• -), 
hydrogen peroxide (H2O2) and hydroxyl radical (OH•).  These oxidant species can inactivate 
enzymes, as well as damage DNA and membrane lipids [154, 155]. Thus, aerobic organisms 
need to maintain an intracellular reducing environment, while living in an oxidizing world. This 
is achieved by making use of different oxidoreductases, able to neutralize harmful species, and 
keeping high concentrations of low-molecular-weight (LMW) thiols, which serve as redox 
buffers, protecting the cell against a variety of stresses including ROS [156].  
The most known LMW thiol is glutathione (GSH), however it is not ubiquitous and 
different organisms contain high concentrations of other sulfur compounds instead, such as 
bacillithiol (BSH), coenzyme A (CoA), cysteine (Cys), ergothienine (ESH) and mycothiol 
(MSH), among others [157, 158]. In general, BSH is the major LMW thiol in firmicutes, GSH in 
eukaryotes and gram-negative bacteria, ESH in fungi and mycobacteria, and MSH in 
actinomycetes. Cys, a reactive amino acid, and CoA, a universal metabolic cofactor, have 
important roles besides redox balance and are present in all organisms [157].  
CoA is an essential cofactor involved in central metabolic pathways, including the Krebs 
cycle and fatty acid metabolism. CoA disulfide reductase (CoADR) is a group-3 flavoprotein 




CoA-disulfide (CoAD) via formation of a protein–S-S-CoA mixed disulfide [159]. NAD(P)H-
dependent CoADRs have been characterized from the pathogenic firmicutes Staphylococcus 
aureus [14, 160] and Bacillus anthracis [161], the Lyme disease spirochete Borrelia burgdorferi 
[162], and the thermophilic anaerobic archaeon Pyrococcus horikoshii [163].  
CoA is resistant to autooxidation at high temperature adding an additional advantage to 
its use as an antioxidant in thermophilic and hyperthermophilic organisms [163, 164]. Thermus 
thermophilus is an aerobic thermophilic organism, with a maximum growth temperature of 
approximately 85 °C, originally isolated from a Japanese hot spring [165]. Although unusual for 
a gram-negative bacterium, T. thermophilus lacks the ability to synthesize GSH, and contains a 
CoADR-like enzyme in its genome, suggesting CoA to have a redox role in this organism [166]. 
Remarkably, the predicted CoADR is also annotated as a type 2 NADH dehydrogenase (NDH-2) 
[12], has been previously isolated from the membrane fraction of the native organism and shown 
to reduce quinones [49, 167]. 
Here, the biochemical characterization of T. thermophilus CoADR (TtCoADR), has been 
re-visited, based on crystallography results (private communication with Julia Preu, Cornelia 
Muenke, Juergen Koepke and Hartmut Michel). This enzyme was previously identified as a type 
2 NADH:quinone oxidoreductase (NDH-2); however, it displays a preference for CoAD over 
quinone and it is present mainly as a soluble dimer in the cytosol. Despite its membrane binding 
capabilities, other studied CoADRs have also been purified for comparison, found in the 
membrane fraction in lesser amounts and able to catalyze quinone reduction at low rates. No 
biological relevance is proposed for this side activity, but it is rather concluded that T. 




characterized as a CoADR, suggesting that T. thermophilus relies on CoA as one of its main 
LMW thiols. 
 
5.2. MATERIALS AND METHODS 
Strains and plasmids 
E. coli and T. thermophilus strains expressing T. thermophilus CoADR were previously 
constructed by Venkatakrishnan et al. [49]. E. coli strains and plasmids expressing B. anthracis, 
P. horikoshii and S. aureus CoADR were kindly provided by Dr. Claiborne, Dr. Parsonage and 
Dr. Crane, respectively [14, 161, 168]. 
 
Cell growth, protein expression and purification  
Recombinant E. coli C43 cells carrying the expression vectors encoding CoADRs were grown at 
37°C in LB medium, supplemented with the correspondent antibiotic, and induced with IPTG as 
described elsewhere [14, 49, 161, 168].  T. thermophilus cells carrying the pMKbcbgaA vector 
were grown in Thermus Broth (TB) medium supplemented with 30 µg/ml kanamycin at 60 °C, 
as previously described [49]. 
Membrane and cytoplasmic fractions were obtained following the protocol for the T. 
thermophilus enzyme [49], with minor modifications.  All procedures were performed at 4°C. 
Briefly, cells were harvested and resuspended in buffer A (50 mM sodium phosphate buffer pH 
7.5, 100 mM NaCl), plus 5 mM MgSO4, DNAse I and protease inhibitor cocktail (Sigma-Aldrich 
Corp., St. Louis, MO, USA). They were then disrupted by passing three times through a 
microfluidizer at 80,000 psi pressure and the resulting extracts were centrifuged at 12,000 x g for 




for 4 h or twice at 150,000 x g for 1 h to separate membrane fractions. When cell extracts were 
centrifuged twice, these were resuspended in buffer A in between centrifugation steps.  
For protein purification, all steps were carried out at 4°C. Membrane pellets were 
resuspended in buffer A plus the protease inhibitor cocktail and solubilized by addition of a stock 
solution of 20 % dodecyl-β-D-maltoside (DDM) dropwise to a final concentration of 1 %. The 
suspension was incubated at 4 °C for 1 h with mild agitation, then cleared by centrifugation at 
65,000 x g for 1 h. Cytoplasmic supernatant and solubilized membranes were added to 5 ml of 
Ni-NTA resin (QIAGEN Sciences, Germantown, MD, USA) pre-equilibrated with buffer A plus 
10 mM imidazole. The protein bound to the resin was washed with buffer A plus 50 mM 
imidazole (or 30 mM for P. horikoshii enzyme) and eluted with buffer A with 200 mM 
imidazole. Buffers used for purification from membrane fractions also contained 0.05% DDM. 
Eluates were concentrated by filtration, and imidazole was removed by a series of filtration and 
washing steps with buffer A. The purified protein could be stored frozen at -80°C after addition 
of glycerol to a final concentration of 10 %. 
 
Sequence and structure analysis 
Sequence alignments were performed using CLUSTAL W [39]. Jalview software was used for 
visualization and analysis [138].  VMD software was used for structure visualization, analysis 
and comparison with existent X-ray structures [140]. 
 
Enzymatic activity assays 
A UV-Vis spectrophotometer (Agilent Technologies, model 8453) was used to follow 




incubation of 2 nM enzyme for 2 minutes at 60°C (or 42°C if specified). All assays were carried 
out in 50 mM sodium phosphate buffer, pH 7.5 and 100-300 mM sodium chloride. No extra 
flavin was added to the reaction mix. Inhibition by p-chloromercuribenzoic acid (PCMB) was 
tested by addition of 1 mM of the compound. 
NAD(P)H:DTNB disulfide reductase: DTNB oxidation/TNB formation was detected by 
following absorbance at 412 nm, in the presence of 100 µM of NAD(P)H and 2 mM of DTNB, 
as previously described [15].  
NAD(P)H:CoAD reductase: NAD(P)H oxidation was determined by the decrease in 
absorbance at 340 nm, in the presence of 200 µM CoADS and 100 µM NAD(P)H, as previously 
described [163]. 
  NAD(P)H oxidase: NAD(P)H oxidation by oxygen was determined by the decrease in 
absorbance at 340 nm, in the presence of 100 µM NAD(P)H under aerobic conditions.  
NAD(P)H peroxidase: NAD(P)H oxidation by H2O2 was determined by the decrease in 
absorbance at 340 nm, in the presence of 10 mM NAD(P)H under aerobic conditions.  
NAD(P)H:quinone reductase: NAD(P)H oxidation was determined by the decrease in 
absorbance at 340 nm, in the presence of 100 µM of the soluble quinone analog menadione 
(MD) and 100 µM NAD(P)H.  
NADH oxidation coupled to E. coli respiratory chain: NAD(P)H oxidation was 
determined by the decrease in absorbance at 340 nm, in the presence of 125 µg/ml of DnuoDndh 
E. coli membranes [47, 169] and 100 µM NAD(P)H. Assays were performed at 42 °C to 
preserve membrane integrity. 
 




The rate of NADH oxidation was determined using a UV-Vis spectrophotometer (Agilent 
Technologies, model 8453) by following absorbance at 340 nm upon addition of 2-200 µM 
NADH to the reaction mix containing 2-200 µM of CoAD and 2 nM enzyme, at 60 °C. Enzyme 
rates are expressed as a turnover number (kcat) based on moles of NADH oxidized per second 
per mol of enzyme (mol NADH s-1 mol enzyme-1). 
 
Analytical methods 
Protein purity was determined by SDS-PAGE using a 4–20% gradient gel (NuSep). The presence 
of recombinant his-tagged proteins was observed by western blot, using the Westernbreeze 
chromogenic kit (Thermo Fisher Scientific). Protein concentration in different cellular fractions 
was determined using the BCA kit (Thermo Fisher Scientific).  
 
5.3. RESULTS 
CoAD is the preferred electron acceptor for TtCoADR  
T. thermophilus CoADR was first shown to have NADH:quinone oxidoreductase activity in vitro 
and designated an NDH-2 [49]. Its X-ray structure however, resembles a CoADR. According to 
this, TtCOADR holds a CoA molecule covalently bound to Cys44 upon purification, that can be 
seen in the structure, close to the FAD and NADH molecule (Fig 5.1). This cysteine corresponds 
to the conserved catalytic residue part of the SFXXC motif present in group 3 FDR enzymes 
[159], although TtCOADR shows a Tyr residue instead of a Phe (SYXXC).  
To understand the specificity of the enzyme for different substrates, activity assays were 
performed in the presence of NDH-2 and CoADR specific substrates: NADH/menadione (MD) 




CoADRs, and other compounds that can react with related FDR enzymes (peroxidase and 
oxidase; H2O2 and O2, air oxidation), were also assayed in combination with NADH (Table 5.1). 
It is worth noticing that addition of 30 µM FAD has been shown to improve quinone 
reductase activity [49]; however, the presence of extra flavin did not improve the disulfide 
reductase activity of the enzyme. 
 
 
Figure 5.1. Coenzyme A binding site. (A) CoA is found covalently bound to Cys44 at the active site 
upon purification. (B) The FAD group interacts with NADH through p-stacking and is aligned with the 








Table 5.1. TtCoADR enzyme activity with different electron acceptor substrates at 60˚C 
Substrate kcat [s-1] 
Menadione a 1.0 ± 0.1 
DTNB b 1.5 ± 0.2 
CoAD a 5.5 ± 0.7 
O2 a 0.3 ± 0.0 
H2O2 a 0.4 ± 0.1 
Activity is expressed as µmoles of aNADH oxidized or bDTNB reduced per second at 60 °C. Data are 
expressed as average ± SD of three independent experiments. 
 
 NADH oxidation in the presence of CoAD is 6-fold higher than the quinone reductase 
activity observed with MD, of 1 electron per second. DTNB is also reduced by TtCoADR at a 
faster rate than MD, yielding a characteristic yellow colored product (TNB-) [168, 170]. 
Furthermore, no disulfide reductase activity is seen after addition of 1 mM of the thiol-reacting 
compound p-chloromercuribenzoic acid (PCMB), which blocks the catalytic cysteine. T. 
thermophilus CoADR also shows low NADH-dependent oxidase and peroxidase activity at 60 
°C, corresponding to ~1/3 of quinone reduction. Oxidase, peroxidase and quinone reductase 
activity were not affected by the presence of PCMB, suggesting the cysteine residue is not 
involved in these reactions. 
 NDH-2s are membrane-bound proteins, able to reduce quinones present in the membrane 
bilayer. Since TtCoADR reduction of quinone in vitro is significantly higher than reduction of 
oxygen or peroxide, enzyme activity was assayed in the presence of NADH and E. coli 
membranes, to test for coupling of NADH oxidation to the respiratory chain. E. coli is able to 




complex I and NDH-2; however, the membranes used for these assays belong to a mutant strain 
lacking both NDH enzymes. Nevertheless, no NADH oxidation was observed by CoADR in the 
presence of these membranes, suggesting the quinone reductase activity would not be relevant in 
vivo. 
 
TtCoADR exclusively oxidizes NADH 
CoADRs catalyze reduction of CoAD via oxidation of NAD(P)H. So far, only CoADRs 
NADPH-dependent (S. aureus and P. horikoshii) or with dual-specificity for NADH/NADPH (B. 
anthracis) have been thoroughly studied [14, 161, 163]. Additionally, a single NADH-dependent 
enzyme has been characterized (B. burgdorferi); however, there is no structure available for this 
last one [162]. 
No quinone [49], oxygen or disulfide reductase activity is observed with NADPH. 
Specificity towards NADH or NADPH can be predicted based on conserved amino acids [161, 
171]. The most commonly described residues, are a glutamate that interacts with the 2’-oxygen 
of the adenosine ribose in NADH, or an arginine, stabilizing the 2’-phosphate of the adenosine in 
NADPH. Sequence alignments of TtCoADR with other CoADRs of known specificity, indicate 
the presence of an NADH binding Glu179, and the absence of an Arg residue, showing an Ala 






Figure 5.2. TtCoADR shows specificity for NADH. (A) T. thermophilus enzyme is predicted to only use 
NADH as a substrate, based on sequence alignments showing the presence of residues for specific 
interaction with NADH (magenta/green) and absence of those specific for NADPH (red) [161]. (B) 
NADH mainly interacts with FAD through p-stacking and hydrogen bonds to few amino acid residues, 
including Glu179. 
 
 Soaking of the crystals with NADH allowed for structure determination of the NADH-
bound structure, as the cofactor gets lost during the purification procedure. In this structure, the 
nicotinamide ring of NADH and the FAD isoalloxazine ring can be seen interacting primarily 
through pi-stacking with only a few protein residues making close connections with NADH. 
Specifically, Glu179 can be seen in close contact with the adenosine ribose (Fig. 5.2B). 
This supports the biochemical results, where no disulfide, oxygen or quinone reductase 
activity is detected upon addition of NADPH to the reaction mix. 
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Other CoADRs can be found in the membrane fraction  
Although T. thermophilus enzyme shows definitive characteristics of a CoADR, including the 
conserved catalytic Cys44, a covalently bound CoA per monomer and a strong resemblance to 
other structures of this family, its isolation from the membrane fraction remained puzzling. To 
investigate if this was a unique feature of the T. thermophilus enzyme, previously characterized 
members of this group were attempted to be purified from the membrane fraction, following the 
same protocol than for TtCoADR (Table 5.2).  
Surprisingly, all tested CoADRs were present in the membrane fraction to a certain 
extent, suggesting no special membrane binding properties for the T. thermophilus enzyme. Most 
enzymes were found mainly in the cytosolic fraction, except for P. horikoshii’s, which was 
found in the cytosolic and membrane fractions at a 2 to 1 ratio. 
 
Table 5.2. Distribution of CoADR in the cell in different organisms  
Organism Cytoplasm:Membrane cTotal Protein (mg/l) 
B. anthracis 14:1 0.5 
P. horikoshii 2:1 1.9 
S. aureusa 95:1 57 
T. thermophilus 95:1 6.4 
T. thermophilusb 15:1 0.1 
aS. aureus with no tag, overexpressed in E. coli BL21; bT. thermophilus enzyme expressed in the native 
organism; cmg of protein purified per liter of culture. 
 
Binding to the membrane could be solely a consequence of overexpression. Therefore, 




TtCoADR gene were assayed for presence of the enzyme. The amount of protein obtained was 
<50-fold than the purified from E. coli, but once again isolation of TtCoADR resulted in a 
cytosol-favored distribution (Table 5.2). Thus, membrane binding does not seem to be driven 
just by an excessive amount of soluble protein. 
 
Quinones can interact with CoADR at the CoAD binding site 
TtCoADR shows NADH oxidation in the presence of soluble quinones, suggesting these analogs 
are able to get electrons from the reduced enzyme. To study the interaction between TtCoADR 
and quinone analogs, the protein structure was analyzed after soaking the crystals with MD. 
 The soaked crystals, show a rather weak electron density for the MD molecule with a 
putative binding pocket at the dimer interface (Fig. 5.3A). However, the two quinone oxygen 
atoms could be identified more clearly, showing the naphtoquinone ring at a close distance from 
the disulfide bridge between the catalytic Cys44 and CoA (Fig. 5.3B). This establishes the 
quinone is able to bind to the enzyme at a position close enough that would allow electron 
transfer from the Cys44-S-S-CoA disulfide or the FAD group. Moreover, given that the quinone 
reductase activity was not inhibited by PCMB, electrons for MD reduction likely derive from the 






Figure 5.3. MD binds at the dimer interface in close vicinity to the active site. (A) MD interacts with 
the enzyme at the interface of the dimer, considered the CoAD binding cleft. (B) Amino acids from both 
monomers can be seen interacting with MD at the binding pocket. 
 
 S. aureus CoADR has been crystallized in the presence of several CoAS-mimetics, which 
irreversibly inhibit the catalytic cysteine [172]. A CoA analogue containing a phenyl vinyl 
sulfone group (PhVS-CoA), shows the phenyl ring at the same site as the naphtoquinone ring in 
TtCoADR when structures are superimposed (Fig 5.4). CoAD is broken down into two CoAS- 
molecules upon reduction: CoAS-I, which initially remains bound to the active cysteine, and 
CoAS-II, which is the first one to be reduced, pick up a proton and leave as CoASH. The 
electron-withdrawing group (Ph-VS) coincides with the proposed CoAS-II site at the CoAD 






Figure 5.4. Menadione (MD) binds at the CoAD binding cleft. The naphthoquinone ring of MD 
reaches the active site of T. thermophilus CoADR through the CoAD binding cleft, binding at the putative 
CoAS-II site described in S. aureus CoADR. The Ph-VS-CoA inhibitor bound to the S. aureus CoADR 
structure is superimposed to represent the CoAS-II site occupied by the phenyl group. 
 
5.4. DISCUSSION 
T. thermophilus NDH-2 is a CoADR 
TtCoADR is misannotated as an NADH oxidase and has been previously characterized as an 
NDH-2 [49, 167]. NDH-2s are dimeric flavoenzymes that reduce NADH, passing on electrons to 
the quinone pool in the membrane. They are part of the respiratory chain, as an alternative to the 
better-known complex I, and are monotopically bound to the cell membrane [23-25]. 
Venkatakrishnan et al., characterized T. thermophilus enzyme based on its flavin content, 
membrane binding properties and NADH:quinone oxidoreductase activity [49]. Although its 
quinone reductase activity was relatively low, it was similar to the reported values by Yagi et al, 
who had isolated it from membranes of the native organism [167]. 
 X-ray crystallization of the T. thermophilus enzyme, purified from E. coli after 




structure [168] (private communication with Julia Preu, Cornelia Muenke, Juergen Koepke and 
Hartmut Michel). TtCoADR structure shows CoAS- bound to the active site Cys44 (part of the 
consensus sequence SFXXC [159]) upon isolation, without the need for further soaking 
experiments, similar to what has been observed for P. horikoshii and S. aureus CoADRs [160, 
168]. The protein also has a non-covalently bound FAD molecule per monomer, located between 
the NADH molecule and the CoA-S-S-Cys44 disulfide bridge (Fig. 5.1B).  
Besides the structural evidence, biochemical studies indicate a preference for CoA over 
quinone (Table 5.1). Moreover, the kinetic parameters for CoAD are comparable to other 
characterized CoADRs for different organisms, with a specificity constant (kcat/Km) of ~8 x 104 
M-1s-1 (PhCoADR ~ 2 x 105, SaCoADR ~ 9 x 106, and BaCoADR ~3 x 107) [161, 163, 172], 
supporting CoA as the preferred substrate for the T. thermophilus enzyme. 
 
TtCoADR is an NADH-dependent enzyme 
Among the previously characterized CoADRs, B. anthracis enzyme is able to reduce CoA by 
oxidizing NADH or NADPH, while others have a strong preference for one dinucleotide over the 
other: S. aureus and P. horikoshii CoADR oxidize mainly NAPDH, while B. burgdorferi 
CoADR prefers NADH [14, 15, 161-163]. TtCoADR is the first solved structure of this family of 
enzymes that exclusively binds NADH. The cofactor is mostly connected to the protein through 
the FAD molecule via p-p interaction similarly to what is observed for other two dinucleotide 
binding domain flavoproteins (tDBDF). In addition, a few protein residues can also be seen in 
close contact, including the conserved acidic residue Glu179, which is less than 3Å away from 




GXGXXGX(17) [D/E/Q]  bab-Rossman dinucleotide binding motif, previously described for 
glutathione reductase and other flavoproteins (Fig. 5.2) [150, 161, 171]. 
 
TtCoADR it able to bind and reduce quinone   
As discussed above, the enzyme active site consists of a FAD cofactor in close vicinity with the 
catalytic Cys44 that covalently binds CoA. The flow of electrons goes from NADH to FAD, to 
Cys44 and finally CoAD, which will be reduced into two molecules of reduced CoA (CoASH).  
 T. thermophilus CoADR shows quinone reductase activity towards several tested soluble 
analogs [49] and a MD-bound structure shows the quinone at the dimer interface (Fig 5.3).  
Other single-cysteine FDRs have been reported to reduce quinones without participation 
of the catalytic cysteine [173]. This is in agreement with what is observed for TtCoADR, where 
the cysteine binding inhibitor PCBM is able to stop disulfide reduction without affecting quinone 
reduction. Thus, MD would be getting reduced directly by FADH2, similarly to what has been 
proposed for Streptococcus faecalis NADH peroxidase [173]. Additionally, no quinone reductase 
activity is observed with NADPH, suggesting the electrons ultimately reducing the quinone 
proceed from NADH. 
 In addition, the S. aureus CoADR structure in the presence of a CoA analogue that 
irreversibly inhibits the catalytic cysteine (PhVS-CoA), shows the phenyl ring at the same site as 
the naphthoquinone ring in TtCoADR, when structures are superimposed [172] (Fig. 5.4). There 
is no CoADR structure with bound CoAD, which is broken down into two CoAS- molecules 
upon reduction: CoAS-I and CoAS-II. The electron-withdrawing group of Ph-VS-CoA (Ph-VS) 
is seen at the proposed CoAS-II site and overlaps with the bound MD, supporting the presence of 





P. horikoshii CoADR is found in the membrane fraction in considerable amounts 
Although the T. thermophilus enzyme was initially isolated from the membrane, S. aureus, B. 
anthracis and P. horikoshii CoADRs could also be found in the membrane fraction to a different 
extent (Table 5.2). It is not surprising this had not seen before, considering purification of 
membrane-bound proteins requires additional ultracentrifugation steps to separate the 
membranes from the cytoplasmic content and solubilization of the membranes using detergent 
(see methods).  
 Most of the analyzed CoADR proteins were found in the membrane fraction in very low 
amounts compared to those found in the cytosolic fraction, with exception of P. horikoshii 
CoADR [168]. PhCoADR corresponds to the only archaeal type, which involves a different lipid 
composition of the cellular membrane that could influence binding. In any event, this finding 
adds to the fact that this particular enzyme shows different specificity towards the disulfide 
substrate, being unable to fit CoAD in its active site and preferring CoA-persulfide and CoA-
polysulfide [168].  
 
T. thermophilus electron transport chain does not encode an NDH-2 
Yagi et al. isolated two types of NADH dehydrogenases from T. thermophilus HB27 
membranes, one corresponding to the multi-subunit complex I and a second one corresponding 
to the single subunit flavoprotein NDH-2 [167]. The characteristics initially described for this 
enzyme helped Venkatakrishnan et al. to further identify and characterize the enzyme after 




T. thermophilus HB27 has been described to have two distinct NADH dehydrogenases: 
complex I and NDH-2 [49], here re-characterized as a CoADR. Although T. thermophilus 
complex I has been widely studied [5, 174] the NDH-2 has been recently excluded from a 
bioinformatic study on this family, based on the identification of new sequence motifs, and 
described to cluster with CoADRs [12]. Moreover, the enzyme originally isolated from T. 
thermophilus membranes by Yagi et al. (1988) was found to be a dihydrolipoyl dehydrogenase 
after mass spectrometry analyses (Takao Yagi, private communication). This protein corresponds 
to the E3 subunit of the pyruvate dehydrogenase complex (and other 2-oxoacid decarboxylases), 
a soluble complex able to oxidize NADH and reduce dihydrolipoic acid into lipoic acid [175].  
In sum, T. thermophilus HB27 seems to rely solely on complex I, the proton translocating 
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